This curriculum vitae outlines the professional experience and qualifications of Anca Maria Cimpean. She is currently a Full Professor of Histology at the Victor Babes University of Medicine and Pharmacy in Timisoara, Romania, where she has worked since 2008. Her areas of expertise include histology, pathology, immunohistochemistry, and tumor angiogenesis research. She has published extensively in peer-reviewed journals, authored book chapters, and her research is cited in scientific literature and on antibody manufacturer websites. She holds a PhD in Histology and has received several awards and fellowships for her academic and scientific work.
This document provides information on hospital information systems (HIS). It defines HIS as integrated systems that manage the medical, administrative, financial and legal aspects of a hospital. The key functions of HIS are to manage the flow and storage of hospital information to best support patient care and outcomes. The main modules of HIS address administration, medical management, resource management, and financial management. The document also provides information on Wipro HIS, a comprehensive hospital automation solution, including its clinical functionality, modules, and implementation in hospitals across India and other regions.
Medical informatics is the application of computers, communications and information technology to medicine. It aims to improve patient care, medical education and research. Key areas include electronic medical records, clinical decision support, telemedicine, evidence-based medicine resources and standards for health data exchange. While technology offers benefits, barriers include costs, expertise and changing behaviors. The field continues to grow with the increased use of mobile devices and need to manage large healthcare datasets.
Medical informatics is the application of computers across all fields of medicine. It deals with the acquisition, storage, and use of medical data and information to aid healthcare services and research. The field has its origins in the 1950s and early computer applications to dentistry and medicine. It encompasses many areas including electronic health records, clinical decision support, telemedicine, and public health informatics. Barriers to the progress of medical informatics include the lack of time, expertise, access to resources and systems, and support for implementation.
This document discusses using an online learning management system called Atutor to supplement classroom teaching for a public health course. It describes how the course content was developed, how Atutor features like resources, forums, and quizzes were utilized, and how students were trained on and adapted to using the online tools. Initially students struggled but over time began using the system more fully to access materials, participate in discussions, and test their understanding through regular quizzes posted by the instructor. The system provided a hybrid learning approach that was well received by the students.
- HealthTech innovation is disrupting healthcare and its established players
- Technology is driving a new paradigm to create better health care
- Developing markets can leapfrog their healthcare infrastructure limitations
- New opportunities are opening to shape the new paradigm
Digital health care technology is transforming hospitals. While technology offers opportunities to improve quality, safety and efficiency, fully digitizing healthcare and replacing clinical judgement with algorithms is still a long way off. Hospitals need to focus on using technology to support, not replace, clinicians. Success requires balancing the needs of people, processes and technology, and managing risks from unintended consequences and legal compliance issues. The ultimate goal remains providing high quality, patient-centered care.
Smartphones have radically changed medicine by giving doctors access to medical information, records, and colleagues from any location. Apps allow remote monitoring of patients and diagnostics like ECG readings. As sensors and artificial intelligence improve, smartphones will take on more medical roles like monitoring organs and managing chronic conditions. While technology expands access to care, doctors will still be needed for human touch, guidance, and complex treatments. Overall, smartphones are transforming healthcare by connecting doctors, patients, and data in new ways.
This document provides information on hospital information systems (HIS). It defines HIS as integrated systems that manage the medical, administrative, financial and legal aspects of a hospital. The key functions of HIS are to manage the flow and storage of hospital information to best support patient care and outcomes. The main modules of HIS address administration, medical management, resource management, and financial management. The document also provides information on Wipro HIS, a comprehensive hospital automation solution, including its clinical functionality, modules, and implementation in hospitals across India and other regions.
Medical informatics is the application of computers, communications and information technology to medicine. It aims to improve patient care, medical education and research. Key areas include electronic medical records, clinical decision support, telemedicine, evidence-based medicine resources and standards for health data exchange. While technology offers benefits, barriers include costs, expertise and changing behaviors. The field continues to grow with the increased use of mobile devices and need to manage large healthcare datasets.
Medical informatics is the application of computers across all fields of medicine. It deals with the acquisition, storage, and use of medical data and information to aid healthcare services and research. The field has its origins in the 1950s and early computer applications to dentistry and medicine. It encompasses many areas including electronic health records, clinical decision support, telemedicine, and public health informatics. Barriers to the progress of medical informatics include the lack of time, expertise, access to resources and systems, and support for implementation.
This document discusses using an online learning management system called Atutor to supplement classroom teaching for a public health course. It describes how the course content was developed, how Atutor features like resources, forums, and quizzes were utilized, and how students were trained on and adapted to using the online tools. Initially students struggled but over time began using the system more fully to access materials, participate in discussions, and test their understanding through regular quizzes posted by the instructor. The system provided a hybrid learning approach that was well received by the students.
- HealthTech innovation is disrupting healthcare and its established players
- Technology is driving a new paradigm to create better health care
- Developing markets can leapfrog their healthcare infrastructure limitations
- New opportunities are opening to shape the new paradigm
Digital health care technology is transforming hospitals. While technology offers opportunities to improve quality, safety and efficiency, fully digitizing healthcare and replacing clinical judgement with algorithms is still a long way off. Hospitals need to focus on using technology to support, not replace, clinicians. Success requires balancing the needs of people, processes and technology, and managing risks from unintended consequences and legal compliance issues. The ultimate goal remains providing high quality, patient-centered care.
Smartphones have radically changed medicine by giving doctors access to medical information, records, and colleagues from any location. Apps allow remote monitoring of patients and diagnostics like ECG readings. As sensors and artificial intelligence improve, smartphones will take on more medical roles like monitoring organs and managing chronic conditions. While technology expands access to care, doctors will still be needed for human touch, guidance, and complex treatments. Overall, smartphones are transforming healthcare by connecting doctors, patients, and data in new ways.
Dokumen tersebut membahas tentang standar dan instrumen akreditasi puskesmas khususnya pada Bab II yang membahas penyelenggaraan upaya kesehatan masyarakat (UKM) yang berorientasi pada upaya promotif dan preventif. Terdapat delapan standar, dua puluh kriteria, dan sembilan puluh empat elemen penilaian yang menjadi acuan pelaksanaan UKM di puskesmas.
Telemedicine and artificial intelligence are transforming healthcare delivery. Today, virtual visits, remote patient monitoring, and telehealth allow patients to access care from home using technologies like online appointments and video conferencing. This improves access and convenience while saving time and costs. Telemedicine is well-suited for rheumatology, as many patients require ongoing medication management that can be done remotely. The future promises even more advanced technologies like wearable health monitors, portable diagnostic devices, and AI assistance with diagnosis and treatment. Faster 5G networks will provide worldwide access to medical data and virtual or augmented reality may enable new types of remote consultations and analysis.
This document provides an overview of clinical decision support systems (CDS). It begins by defining clinical decisions and decision making, and discusses some of the pitfalls of human decision making. The roles of information technology in clinical decision making are then examined. The document defines CDS and provides examples of different types of CDS, including alerts and reminders, reference tools, order sets, and diagnostic decision support. It also reviews CDS architecture and discusses issues related to CDS implementation, such as usability, alert fatigue, and unintended consequences. The document concludes by emphasizing that CDS should supplement rather than replace clinicians and that both technical and human factors must be considered in CDS design.
The document provides an overview of the Student Industrial Work Experience Scheme (SIWES) in Nigeria and Bioraj Pharmaceutical Limited, where the author completed an internship. SIWES was established in 1973 to bridge the skills gap between what graduates learn and what the job market requires. It has contributed to students' personal and professional development. Bioraj Pharmaceutical is a private company located in Ilorin, Nigeria that manufactures drugs and has departments for administration, raw materials, and production. The production department oversees drug manufacturing and packaging.
Group Assignment: HEALTH INFORMATION TECHNOLOGYWafeeqa Wafiq
Health information technology (HIT) has the potential to improve healthcare delivery by increasing efficiency, quality, safety and reducing costs. HIT provides electronic medical records, clinical decision support and computerized physician order entry. The document discusses how HIT can help reduce medical errors and improve various aspects of the healthcare system. Key components of successful HIT implementation include technical, human, project management and organizational change factors.
This document is a curriculum vitae for Anca Maria Cimpean, MD, PhD that includes her contact information, work experience, education and training history, publications, skills, and awards. It details that she is currently a Full Professor of Histology at the Victor Babes University of Medicine and Pharmacy in Timisoara, Romania, with experience in histology, pathology, microscopy, and tumor angiogenesis research. Her education includes residencies in pathology and general practice medicine as well as a PhD focused on tumor angiogenesis. She has over 50 publications in peer-reviewed journals and serves as an evaluator for medical research projects.
This document provides a summary of Evmorfia Tzagkaraki's resume. She has over 15 years of experience as a molecular biologist and geneticist. Currently, she is the Head of the Molecular Biology Department at Diagnosis Medical Diagnostic Centre in Rethymnon, Greece, where she helped develop the department. Previously, she was Head of Laboratory at Omnigen Biotechnological Applications SA. She holds a PhD in molecular investigation of genetic diseases from the University of Crete and has published papers in peer-reviewed journals. She is proficient in molecular biology techniques and has experience managing medical laboratories.
Attracting over 3,300 drug discovery and development professionals from over 40 countries in 2015, the Tri-Conference has grown into a diverse event, focusing on Molecular Medicine, specifically on Discovery, Genomics, Diagnostics and Information Technology.
With a 23 year history, this year’s expanded coverage includes additional programs on Molecular Diagnostics for Infectious Disease, Precision Medicine and Cancer Immunotherapy, as well as two new symposia on Companion Diagnostics and the Commercialization of Molecular Diagnostics.
The document is a curriculum vitae for Gokhan Baris Ozdener. It summarizes his educational background which includes a DDS from Ege University School of Dental Medicine and a D.Sc. in Molecular and Cell Biology from Boston University. It also outlines his professional experience as a postdoctoral associate at Boston University and prior research assistant roles. Finally, it lists his research interests and publications which are focused on molecular biology, cancer research, and the cellular uptake pathways of lysyl oxidase propeptide.
This Advanced Haematology course focuses on various anemia types, Leukemia, hematological disorders, chromosomal studies related to these disorders, and the use of radioisotopes in haematology. The course also addresses the importance of safety measures regarding radiation hazards and the disposal of radioactive materials.
Created by: Mr. Attuluri Vamsi Kumar, Assistant Professor, Department of MLT, UIAHS, Chandigarh University, Mohali, Punjab. For more details website: https://www.mltmaster.com
This course in "Virology and Mycology" (701) is designed to provide a comprehensive understanding of the medically important fungi and viruses. The content includes an introduction, general characteristics, life cycle, laboratory diagnosis, and the various techniques used in the identification and study of these microbes. This course will also equip students with practical skills, from preparing culture media to processing clinical samples for diagnosis.
Created by: Mr. Attuluri Vamsi Kumar, Assistant Professor, Department of MLT, UIAHS, Chandigarh University, Mohali, Punjab. For more details website: https://www.mltmaster.com
This syllabus of Medical Parasitology and Entomology aims to equip students with the understanding of medically important parasites. This includes their general characteristics, life cycle, and laboratory diagnosis. The students will also learn different diagnostic procedures including stool examination, blood examination, and specialized diagnostic techniques for various parasites. Practical experiments are an integral part of this syllabus, enhancing the students' understanding and skills.
Created by: Mr. Attuluri Vamsi Kumar, Assistant Professor, Department of MLT, UIAHS, Chandigarh University, Mohali, Punjab. For more details website: https://www.mltmaster.com
This course offers Medical Lab Technology students a comprehensive insight into Clinical Pathology and Histopathology through a series of visits to these laboratories. Through structured units, students will gain foundational knowledge, observe advanced techniques, and explore emerging trends in these fields. They will also apply their knowledge through a series of relevant case studies.
Created by: Mr. Attuluri Vamsi Kumar, Assistant Professor, Department of MLT, UIAHS, Chandigarh University, Mohali, Punjab. For more details website: https://www.mltmaster.com
The document provides information about the 4th Microbiome R&D and Business Collaboration Forum and Probiotics Congress that will take place from 3-4 October 2016 in La Jolla, San Diego. The conference will explore research on the human microbiome and its role in health and disease, as well as commercial opportunities. Over 250 attendees are expected, including leading academics and industry experts who will give presentations on topics like gut and skin microbiota, probiotics, and commercializing microbiome research. The schedule provides details on speakers, session topics, sponsors, and arrangements.
This document provides a summary of Aaron M Bender's background and experience. It includes his contact information, educational background which includes a PhD in Molecular Biology from the University of Wyoming, and extensive research experience including positions at ArcherDX, the University of Kansas Molecular Probes Core Laboratory, the University of Kansas, and the Mayo Clinic where he conducted research in areas such as cancer genetics, chemical biology, next generation sequencing, and the use of model organisms like C. elegans. He has over 15 publications in peer-reviewed journals.
This document contains the resume of P. Shasha, who has over 10 years of experience working as a medical laboratory technologist and manager in Hyderabad, India. He holds a post-graduate diploma in medical laboratory technology and bachelor's degrees. His skills include experience with laboratory procedures, machines, and diagnostics in areas like pathology, biochemistry, microbiology, and transfusion medicine. He is currently seeking new opportunities in medical devices or diagnostic applications.
This document contains the resume of P. Shasha, who has over 10 years of experience working as a medical laboratory technologist and manager in Hyderabad, India. He holds a post-graduate diploma in medical laboratory technology and bachelor's degrees. Shasha seeks to further his career in medical devices and has experience working with various diagnostic equipment and performing procedures in pathology, biochemistry, microbiology, and transfusion medicine. He provides contact information, educational background, work experience, skills, and references.
This document describes a study using multiphoton microscopy (MPM) to image intrinsic fluorescence in splenic tissue from a mouse model of sickle cell disease (SCD). MPM was used to identify distinct morphological and spectral features associated with SCD, including spectrally unique iron-complex deposits. These deposits were found at higher concentrations in diseased tissue compared to healthy tissue. Identification of these biomarkers could provide insight into immune dysfunction and organ malfunction in SCD. Histological staining and white light microscopy were also used for comparison.
This curriculum vitae summarizes the educational and professional experience of Mirta Milić. She received her PhD in 2010 from the Faculty of Science in Zagreb, Croatia. Since 2011, she has worked as a Scientific Associate at the Institute for Medical Research and Occupational Health in Zagreb, focusing on genotoxicology and genetic monitoring. She also spent over a year as a postdoctoral fellow at the IRCCS San Raffaele Pisana in Rome, Italy from 2013-2014. Her research interests include genetic toxicology, biomarkers of exposure to various agents, and genetic monitoring. She has authored or co-authored several peer-reviewed publications in her field.
Microbiome & Probiotics Forum USA agenda 2017Gavin Hambrook
Here's our new look agenda for the Microbiome and Probiotics Forum in San Diego this November. What do you think?
50+ speakers
30+ sponsors
400+ attendees
This document provides information about the 5th International Conference and Exhibition on World Metabolomics 2016 that will take place from May 16-18, 2016 in Osaka, Japan. It discusses the conference themes, sessions, speakers and highlights. It also lists the conference secretariat contact information and invites industrial and academic researchers to participate.
Dokumen tersebut membahas tentang standar dan instrumen akreditasi puskesmas khususnya pada Bab II yang membahas penyelenggaraan upaya kesehatan masyarakat (UKM) yang berorientasi pada upaya promotif dan preventif. Terdapat delapan standar, dua puluh kriteria, dan sembilan puluh empat elemen penilaian yang menjadi acuan pelaksanaan UKM di puskesmas.
Telemedicine and artificial intelligence are transforming healthcare delivery. Today, virtual visits, remote patient monitoring, and telehealth allow patients to access care from home using technologies like online appointments and video conferencing. This improves access and convenience while saving time and costs. Telemedicine is well-suited for rheumatology, as many patients require ongoing medication management that can be done remotely. The future promises even more advanced technologies like wearable health monitors, portable diagnostic devices, and AI assistance with diagnosis and treatment. Faster 5G networks will provide worldwide access to medical data and virtual or augmented reality may enable new types of remote consultations and analysis.
This document provides an overview of clinical decision support systems (CDS). It begins by defining clinical decisions and decision making, and discusses some of the pitfalls of human decision making. The roles of information technology in clinical decision making are then examined. The document defines CDS and provides examples of different types of CDS, including alerts and reminders, reference tools, order sets, and diagnostic decision support. It also reviews CDS architecture and discusses issues related to CDS implementation, such as usability, alert fatigue, and unintended consequences. The document concludes by emphasizing that CDS should supplement rather than replace clinicians and that both technical and human factors must be considered in CDS design.
The document provides an overview of the Student Industrial Work Experience Scheme (SIWES) in Nigeria and Bioraj Pharmaceutical Limited, where the author completed an internship. SIWES was established in 1973 to bridge the skills gap between what graduates learn and what the job market requires. It has contributed to students' personal and professional development. Bioraj Pharmaceutical is a private company located in Ilorin, Nigeria that manufactures drugs and has departments for administration, raw materials, and production. The production department oversees drug manufacturing and packaging.
Group Assignment: HEALTH INFORMATION TECHNOLOGYWafeeqa Wafiq
Health information technology (HIT) has the potential to improve healthcare delivery by increasing efficiency, quality, safety and reducing costs. HIT provides electronic medical records, clinical decision support and computerized physician order entry. The document discusses how HIT can help reduce medical errors and improve various aspects of the healthcare system. Key components of successful HIT implementation include technical, human, project management and organizational change factors.
This document is a curriculum vitae for Anca Maria Cimpean, MD, PhD that includes her contact information, work experience, education and training history, publications, skills, and awards. It details that she is currently a Full Professor of Histology at the Victor Babes University of Medicine and Pharmacy in Timisoara, Romania, with experience in histology, pathology, microscopy, and tumor angiogenesis research. Her education includes residencies in pathology and general practice medicine as well as a PhD focused on tumor angiogenesis. She has over 50 publications in peer-reviewed journals and serves as an evaluator for medical research projects.
This document provides a summary of Evmorfia Tzagkaraki's resume. She has over 15 years of experience as a molecular biologist and geneticist. Currently, she is the Head of the Molecular Biology Department at Diagnosis Medical Diagnostic Centre in Rethymnon, Greece, where she helped develop the department. Previously, she was Head of Laboratory at Omnigen Biotechnological Applications SA. She holds a PhD in molecular investigation of genetic diseases from the University of Crete and has published papers in peer-reviewed journals. She is proficient in molecular biology techniques and has experience managing medical laboratories.
Attracting over 3,300 drug discovery and development professionals from over 40 countries in 2015, the Tri-Conference has grown into a diverse event, focusing on Molecular Medicine, specifically on Discovery, Genomics, Diagnostics and Information Technology.
With a 23 year history, this year’s expanded coverage includes additional programs on Molecular Diagnostics for Infectious Disease, Precision Medicine and Cancer Immunotherapy, as well as two new symposia on Companion Diagnostics and the Commercialization of Molecular Diagnostics.
The document is a curriculum vitae for Gokhan Baris Ozdener. It summarizes his educational background which includes a DDS from Ege University School of Dental Medicine and a D.Sc. in Molecular and Cell Biology from Boston University. It also outlines his professional experience as a postdoctoral associate at Boston University and prior research assistant roles. Finally, it lists his research interests and publications which are focused on molecular biology, cancer research, and the cellular uptake pathways of lysyl oxidase propeptide.
This Advanced Haematology course focuses on various anemia types, Leukemia, hematological disorders, chromosomal studies related to these disorders, and the use of radioisotopes in haematology. The course also addresses the importance of safety measures regarding radiation hazards and the disposal of radioactive materials.
Created by: Mr. Attuluri Vamsi Kumar, Assistant Professor, Department of MLT, UIAHS, Chandigarh University, Mohali, Punjab. For more details website: https://www.mltmaster.com
This course in "Virology and Mycology" (701) is designed to provide a comprehensive understanding of the medically important fungi and viruses. The content includes an introduction, general characteristics, life cycle, laboratory diagnosis, and the various techniques used in the identification and study of these microbes. This course will also equip students with practical skills, from preparing culture media to processing clinical samples for diagnosis.
Created by: Mr. Attuluri Vamsi Kumar, Assistant Professor, Department of MLT, UIAHS, Chandigarh University, Mohali, Punjab. For more details website: https://www.mltmaster.com
This syllabus of Medical Parasitology and Entomology aims to equip students with the understanding of medically important parasites. This includes their general characteristics, life cycle, and laboratory diagnosis. The students will also learn different diagnostic procedures including stool examination, blood examination, and specialized diagnostic techniques for various parasites. Practical experiments are an integral part of this syllabus, enhancing the students' understanding and skills.
Created by: Mr. Attuluri Vamsi Kumar, Assistant Professor, Department of MLT, UIAHS, Chandigarh University, Mohali, Punjab. For more details website: https://www.mltmaster.com
This course offers Medical Lab Technology students a comprehensive insight into Clinical Pathology and Histopathology through a series of visits to these laboratories. Through structured units, students will gain foundational knowledge, observe advanced techniques, and explore emerging trends in these fields. They will also apply their knowledge through a series of relevant case studies.
Created by: Mr. Attuluri Vamsi Kumar, Assistant Professor, Department of MLT, UIAHS, Chandigarh University, Mohali, Punjab. For more details website: https://www.mltmaster.com
The document provides information about the 4th Microbiome R&D and Business Collaboration Forum and Probiotics Congress that will take place from 3-4 October 2016 in La Jolla, San Diego. The conference will explore research on the human microbiome and its role in health and disease, as well as commercial opportunities. Over 250 attendees are expected, including leading academics and industry experts who will give presentations on topics like gut and skin microbiota, probiotics, and commercializing microbiome research. The schedule provides details on speakers, session topics, sponsors, and arrangements.
This document provides a summary of Aaron M Bender's background and experience. It includes his contact information, educational background which includes a PhD in Molecular Biology from the University of Wyoming, and extensive research experience including positions at ArcherDX, the University of Kansas Molecular Probes Core Laboratory, the University of Kansas, and the Mayo Clinic where he conducted research in areas such as cancer genetics, chemical biology, next generation sequencing, and the use of model organisms like C. elegans. He has over 15 publications in peer-reviewed journals.
This document contains the resume of P. Shasha, who has over 10 years of experience working as a medical laboratory technologist and manager in Hyderabad, India. He holds a post-graduate diploma in medical laboratory technology and bachelor's degrees. His skills include experience with laboratory procedures, machines, and diagnostics in areas like pathology, biochemistry, microbiology, and transfusion medicine. He is currently seeking new opportunities in medical devices or diagnostic applications.
This document contains the resume of P. Shasha, who has over 10 years of experience working as a medical laboratory technologist and manager in Hyderabad, India. He holds a post-graduate diploma in medical laboratory technology and bachelor's degrees. Shasha seeks to further his career in medical devices and has experience working with various diagnostic equipment and performing procedures in pathology, biochemistry, microbiology, and transfusion medicine. He provides contact information, educational background, work experience, skills, and references.
This document describes a study using multiphoton microscopy (MPM) to image intrinsic fluorescence in splenic tissue from a mouse model of sickle cell disease (SCD). MPM was used to identify distinct morphological and spectral features associated with SCD, including spectrally unique iron-complex deposits. These deposits were found at higher concentrations in diseased tissue compared to healthy tissue. Identification of these biomarkers could provide insight into immune dysfunction and organ malfunction in SCD. Histological staining and white light microscopy were also used for comparison.
This curriculum vitae summarizes the educational and professional experience of Mirta Milić. She received her PhD in 2010 from the Faculty of Science in Zagreb, Croatia. Since 2011, she has worked as a Scientific Associate at the Institute for Medical Research and Occupational Health in Zagreb, focusing on genotoxicology and genetic monitoring. She also spent over a year as a postdoctoral fellow at the IRCCS San Raffaele Pisana in Rome, Italy from 2013-2014. Her research interests include genetic toxicology, biomarkers of exposure to various agents, and genetic monitoring. She has authored or co-authored several peer-reviewed publications in her field.
Microbiome & Probiotics Forum USA agenda 2017Gavin Hambrook
Here's our new look agenda for the Microbiome and Probiotics Forum in San Diego this November. What do you think?
50+ speakers
30+ sponsors
400+ attendees
This document provides information about the 5th International Conference and Exhibition on World Metabolomics 2016 that will take place from May 16-18, 2016 in Osaka, Japan. It discusses the conference themes, sessions, speakers and highlights. It also lists the conference secretariat contact information and invites industrial and academic researchers to participate.
The document summarizes information about the University Dunarea de Jos in Galati, Romania. It describes several faculties and research centers at the university, including the Faculty of Food Science and Engineering. It provides details about a research project called BIOALIMENT Platform that aims to develop biotechnology applied to the food industry. It also lists some research areas and publications of the university's Romanian team who plans to collaborate with partners in Bulgaria on a new project to develop functional foods and beverages.
The document summarizes information about the University Dunarea de Jos in Galati, Romania. It describes several faculties and research centers at the university, including the Faculty of Food Science and Engineering. It provides details about a research project called BIOALIMENT Platform that aims to develop biotechnology applied to the food industry. It also lists some research areas and publications of faculty members, such as investigating biologically active substances from foods and beverages. Finally, it outlines plans for a bilateral collaboration between the university and a Bulgarian partner on developing functional foods and beverages.
The document discusses how technology has helped shed light on cancer through research using large facilities like synchrotron radiation and neutron laboratories. Over 100,000 protein structures have been determined using these techniques to better understand biochemical processes and design drugs. Countries are investing in new facilities to advance scientific development and tackle challenges like cancer. Nanotechnology and drug delivery systems combined with characterization techniques can improve cancer treatment methods.
Kerry L. Slater has extensive education and experience in microbiology, immunology, and healthcare. She has a B.S. in Microbiology and a M.S. in Molecular and Cellular Immunology & Microbial Genetics from Oregon State University. She has worked as a laboratory technician, monitor tech, certified nursing assistant, and office manager. She is skilled in microbiology techniques, immunology, and providing patient care.
HETEROGENEITY OF C ERB B FAMILY MEMBERS EXPRESSION IS RELATED TO CELL MORPHOL...ANCA MARIA CIMPEAN
This document summarizes a study examining the expression of HER2 and EGFR in pituitary adenomas and their relationship to hormone profiles. The study found that over one-third of pituitary adenomas expressed HER2, particularly prolactin-secreting adenomas. HER2 expression was also related to certain hormone co-expressions. Approximately half of adenomas expressed EGFR, which was correlated with GH-prolactin co-expression. The results suggest HER2 and EGFR expression may help define subclasses of pituitary adenomas and explain their clinical heterogeneity.
OVEREXPRESSION OF VEGF AND VEGFR2 IN CHRONIC HEPATITIS AND LIVER CIRRHOSISANCA MARIA CIMPEAN
VEGF (vascular endothelial growth factor) and the receptor for VEGF- Flk-1 (fetal liver kinase 1) are important players of normal and pathologic angiogenesis. Also, it was proved that they are involved in tumor progression and metastasis in many tumors types by overexpression in cancer cells. Liver malignances and premalignant lesions represent controversial issues concerning VEGF and VEGFR2 (vascular endothelial growth factor receptor 2) expression and their potential involvement in the progression of inflammatory and cirrhotic lesions and also in malignant transformation is virtually unknown. The aim of this work was to describe the differentiate expression and distribution of VEGF and VEGFR2 in chronic hepatitis and liver cirrhosis, and according to these findings to better characterize the molecular profiling of liver disease with malignant transformation potential. We investigated 20 cases with chronic hepatitis and cirrhosis on specimens taken during surgery. Immunohistochemistry was performed in all cases for VEGF, VEGFR2, and FVIII related antigen (Von Willebrand factor). We found significant correlation between HAI (histological activity index) value, VEGF and VEGFR2 expression and factor FVIII related antigen in central part of specimens with chronic hepatitis. Liver cirrhosis lacks this correlation. Our findings suggested that VEGF dependent angiogenesis is more active in chronic hepatitis in the center of the lesion compared with cirrhosis where MVD (microvessel density) is higher at the periphery of the nodules. We hypothesize that the involvement of VEGF and VEGFR2 complex in development of chronic hepatitis and liver cirrhosis could be considered for the use of anti VEGF antibodies as adjuvant therapy in early stages of these diseases.
Key Words: VEGF, VEGFR 2, liver cirrhosis, chronic hepatitis
EXPRESSION OF CK5 BASAL CYTOKERATIN DURING METASTATIC DEVELOPMENT OF BREAST C...ANCA MARIA CIMPEAN
Objective. Breast cancer is a one of the most common cancers in females worldwide. Basal cytokeratin CK5 represent the marker of progenitors for glandular and myoepithelial lineages of mammary epithelium. During epithelial differentiation there is a gradual decrease of CK5 expression. The purpose of this study was to compare the expression of basal cytokeratin CK5 vs hormone receptors, HER2, Ki67 and molecular subtypes immunohistochemically defined in the primary breast carcinoma of NST type and axillar lymph node metastasis. Material and Methods. We processed immunohistochemically 91 invasive breast carcinomas of NST type and their ipsilateral axillar lymph node metastasis (LNM). Results. The majority of primary tumors were evaluated as CK5 negative (78 cases/85.7%). The majority of cases were evaluated as Luminal B (50 cases/54.9%) and Luminal A (28 cases/30.8%) tumors. The HER2 subtype was confirmed in 8 cases/8.8%, 5NP in 3 cases/3.3% and Basal-like in 2 cases/2.2%. The parallel comparison of CK5 expression at both sites, primary and metastatic, revealed that this marker is not stable during metastatic progression. The molecular subtypes were not stable during metastatic process in 21 cases/23.1%. Conclusions. The majority of NST invasive ductal breast carcinomas are CK5 negative. The molecular subtypes and CK5 are not stable during metastatic process. Cancerous cells prefer to lose this marker in the lymph node environment. The presence of cases with simultaneous expression of CK5 and hormone receptors is an open field to debate the existence of other, transient molecular subtypes. We expect a further confirmation in larger study groups.
Key Words: molecular subtypes, invasive carcinoma NST type, basal cytokeratin.
IS THERE STILL A PLACE FOR LIVER BIOPSY FOR THE EVALUATION OF CHRONIC LIVER D...ANCA MARIA CIMPEAN
This document discusses non-invasive methods for assessing chronic liver disease as alternatives to liver biopsy. It describes several biological tests and ultrasound-based elastography methods that can evaluate liver fibrosis and inflammation without invasive procedures. While these non-invasive methods have largely replaced liver biopsy in clinical practice, the document argues that biopsy still provides important information in some cases, such as when non-invasive tests produce uncertain or conflicting results or when diseases require assessment of morphological features in addition to fibrosis.
THERAPEUTIC POTENTIAL OF ANGIOGENESIS INHIBITOR MIXTURES IN CANCER TREATMENT,...ANCA MARIA CIMPEAN
ABSTRACT
It is generally understood that improvement of cancer therapies is achieved by the combination of drugs. This approach will improve efficacy, while toxicity and the risk for drug resistance may be decreased. In this review, the efforts on combining drugs for the treatment of two tumor types is highlighted, followed by a description of the challenges that are faced in designing optimal combination therapies.
WHO APPEARED FIRST IN OTOLARYNGOLOGY: CLINICIANS, ANATOMISTS OR HISTOLOGISTS?...ANCA MARIA CIMPEAN
HISTORICAL REVIEW
Otolaryngology is mainly associated with clinical practice. Despite of this actual evidence, otolaryngology can be considered, from historical point of view as a complex speciality made up of a mixture of several preclinical specialities as anatomy, histology, pathology and physiology. Several scientists who studied these specialities first, became then otolaryngologists and others were known in the medical literature because of their studies in other specialities than otolaryngology. Most of the historical papers were focused on the ear, other regions being neglected. This review presents the forgotten part of otolaryngology, especially its preclinical facts with importance in etiology and pathogenesis of various disease of the ear, nose and throat structures and thus, present work can be considered as a particular overview of „forgotten” otolaryngology.
Key words: otolaryngology, anatomy, histology, pathology
LIMITS OF ANTI-ANGIOGENIC THERAPY, Domenico Ribatti, Beatrice NicoANCA MARIA CIMPEAN
This document discusses limitations of anti-angiogenic therapy for treating cancer. It explains that tumors can develop resistance to anti-angiogenic drugs by activating alternative angiogenic pathways or recruiting pericytes to support new blood vessel growth. While initial studies showed promise, clinical trials found only modest increases in progression-free survival and no enduring responses. The document also notes that anti-angiogenic therapy may paradoxically cause tumors to become more invasive and metastatic in some cases. Combination therapies targeting multiple angiogenic factors or pericytes may be needed to overcome resistance.
This document introduces a new medical journal called Research and Clinical Medicine. It was created to address the need for a precise landscape on narrow medical topics, as articles on the same topics are published across different journals. The journal aims to better translate basic research findings into clinical practice as quickly as possible. It will provide a platform for researchers, clinicians, and students to share experiences and apply research results directly to patient care. The open-access format of the journal will allow for rapid, worldwide dissemination of information to help authors share their work globally.
How to Setup Warehouse & Location in Odoo 17 InventoryCeline George
In this slide, we'll explore how to set up warehouses and locations in Odoo 17 Inventory. This will help us manage our stock effectively, track inventory levels, and streamline warehouse operations.
This document provides an overview of wound healing, its functions, stages, mechanisms, factors affecting it, and complications.
A wound is a break in the integrity of the skin or tissues, which may be associated with disruption of the structure and function.
Healing is the body’s response to injury in an attempt to restore normal structure and functions.
Healing can occur in two ways: Regeneration and Repair
There are 4 phases of wound healing: hemostasis, inflammation, proliferation, and remodeling. This document also describes the mechanism of wound healing. Factors that affect healing include infection, uncontrolled diabetes, poor nutrition, age, anemia, the presence of foreign bodies, etc.
Complications of wound healing like infection, hyperpigmentation of scar, contractures, and keloid formation.
How to Manage Your Lost Opportunities in Odoo 17 CRMCeline George
Odoo 17 CRM allows us to track why we lose sales opportunities with "Lost Reasons." This helps analyze our sales process and identify areas for improvement. Here's how to configure lost reasons in Odoo 17 CRM
বাংলাদেশের অর্থনৈতিক সমীক্ষা ২০২৪ [Bangladesh Economic Review 2024 Bangla.pdf] কম্পিউটার , ট্যাব ও স্মার্ট ফোন ভার্সন সহ সম্পূর্ণ বাংলা ই-বুক বা pdf বই " সুচিপত্র ...বুকমার্ক মেনু 🔖 ও হাইপার লিংক মেনু 📝👆 যুক্ত ..
আমাদের সবার জন্য খুব খুব গুরুত্বপূর্ণ একটি বই ..বিসিএস, ব্যাংক, ইউনিভার্সিটি ভর্তি ও যে কোন প্রতিযোগিতা মূলক পরীক্ষার জন্য এর খুব ইম্পরট্যান্ট একটি বিষয় ...তাছাড়া বাংলাদেশের সাম্প্রতিক যে কোন ডাটা বা তথ্য এই বইতে পাবেন ...
তাই একজন নাগরিক হিসাবে এই তথ্য গুলো আপনার জানা প্রয়োজন ...।
বিসিএস ও ব্যাংক এর লিখিত পরীক্ষা ...+এছাড়া মাধ্যমিক ও উচ্চমাধ্যমিকের স্টুডেন্টদের জন্য অনেক কাজে আসবে ...
How to Add Chatter in the odoo 17 ERP ModuleCeline George
In Odoo, the chatter is like a chat tool that helps you work together on records. You can leave notes and track things, making it easier to talk with your team and partners. Inside chatter, all communication history, activity, and changes will be displayed.
This presentation was provided by Steph Pollock of The American Psychological Association’s Journals Program, and Damita Snow, of The American Society of Civil Engineers (ASCE), for the initial session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session One: 'Setting Expectations: a DEIA Primer,' was held June 6, 2024.
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Cv cimpean 2020. updated.1
1. Page 1/20 - Curriculum vitae of
Surname(s) First name()
Anca Maria Cimpean, MD, PhD
Curriculum
Vitae
First name(s) /
Surname(s)
ANCA MARIA CIMPEAN, MD, PhD, Hab.Dr.
Address(es) PIATA EFTIMIE MURGU 2, 300041, TIMISOARA, ROMANIA
Telephone(s) 0040256204476 Mobile: 0040720060955
E-
mail
ancacimpean1972@yahoo.com
Nationality Romanian
Date of birth 02.07.1972
Gender Female
Work experience
Dates ACADEMIC EXPERIENCE
2014- PRESENT FULL PROFESSOR OF HISTOLOGY, DEPARTMENT OF MICROSCOPIC
MORPHOLOGY/HISTOLOGY, ANGIOGENESIS RESEARCH CENTER, “VICTOR BABES” UNIVERSITY OF
MEDICINE AND PHARMACY, TIMISOARA, ROMANIA
2011-2014. ASSOCIATE PROFESSOR, DEPARTMENT OF MICROSCOPIC MORPHOLOGY/HISTOLOGY,
ANGIOGENESIS RESEARCH CENTER, “VICTOR BABES” UNIVERSITY OF MEDICINE AND PHARMACY,
TIMISOARA, ROMANIA
2008-2011 LECTURER ASSISTANT, DEPARTMENT OF MICROSCOPIC MORPHOLOGY/HISTOLOGY,
ANGIOGENESIS RESEARCH CENTER, “VICTOR BABES” UNIVERSITY OF MEDICINE AND PHARMACY,
TIMISOARA, ROMANIA. www.angiotm.com
Occupation or
position held
2020- MEMBER OF ROMANIAN ASSOCIATION OF SCIENTIFIC EDITORS
2020- MEMBER OF EUROPEAN ASSOCIATION OF SCIENTIFIC EDITORS
2020- MEMBER OF THE NATIONAL CENTER OF VASCULAR MALFORMATIONS TIMISOARA,
ROMANIA
2016-SENIOR RESEARCHER AND MEDICAL STUDENTS COORDINATOR OF MEDICAL
STUDENTS ANGIOGENESIS RESEARCH GROUP AND VADA PROGRAM IN HISTOLOGY,
www.angiotm.com
2012-PRESENT: MEMBER OF THE ACADEMIC GROUP FOR TEACHING QUALITY EVALUATION
OF VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA, ROMANIA
(DEACE)
2014-PRESENT: ASSOCIATE EDITOR OF RESEARCH AND CLINICAL MEDICINE JOURNAL,
www.resclinmed.eu
2004-2008/ASSISTANT PROFESSOR , DEPARTMENT OF MICROSCOPIC
MORPHOLOGY/HISTOLOGY, ANGIOGENESIS RESEARCH CENTER, “VICTOR BABES”
UNIVERSITY OF MEDICINE AND PHARMACY, TIMISOARA, ROMANIA
2010- PRESENT- SPECIALIST IN ANATOMIC PATHOLOGY according with the decision of
HEALTH MINISTRY no.1535/23.12.2010 based on national exam from 19.10.2010, passed with
8.85.
2013- HABILITATION THESIS DISSERTATION and PhD supervisor according with decision of
GENERAL COUNCIL OF CNATDCU and decision of NATIONAL EDUCATION MINISTRY no.
5633MD/11.12.2013.
2002-2004- PhD STUDENT IN MEDICINE/HISTOLOGY, DEPARTMENT OF MICROSCOPIC
MORPHOLOGY/HISTOLOGY, ANGIOGENESIS RESEARCH CENTER, “VICTOR BABES”
UNIVERSITY OF MEDICINE AND PHARMACY, TIMISOARA, ROMANIA
1998-2002- GENERAL PRACTITIONER, CLINICAL COUNTY HOSPITAL NR.1, TIMISOARA,
ROMANIA
2004-2008/ASSISTANT PROFESSOR, DEPARTMENT OF MICROSCOPIC MORPHOLOGY/HISTOLOGY,
ANGIOGENESIS RESEARCH CENTER, “VICTOR BABES” UNIVERSITY OF MEDICINE AND PHARMACY,
TIMISOARA, ROMANIA
2007- PhD THESSIS DISSERTATION-PhD with “SUMMA CUM LAUDE” DISTINCTION, DIPLOMA NR.
50/21.04.2008 BASED ON EDUCATION AND RESEARCH MINISTRY DECISION NR. 3439/12.03.2008
2002-2004- PhD STUDENT IN MEDICINE/HISTOLOGY, DEPARTMENT OF MICROSCOPIC
MORPHOLOGY/HISTOLOGY, ANGIOGENESIS RESEARCH CENTER, “VICTOR BABES” UNIVERSITY OF
MEDICINE AND PHARMACY, TIMISOARA, ROMANIA
1998-2002- GENERAL PRACTITIONER, CLINICAL COUNTY HOSPITAL NR.1, TIMISOARA, ROMANIA
Main activities
and
responsibilities
MEMBER OFANGIOGENESIS RESEARCH CENTER TIMISOARA INCLUDING THE PRIMARY
PROCESSING , MORPHOLOGIC, HISTOCHEMICAL , IMMUNOHISTOCHEMICAL AND FISH
LABORATORIES. RESEARCH ON TUMOR ANGIOGENESIS FIELD AND MOLECULAR MEDICINE
METHODS.
2. Page 2/20 - Curriculum vitae of
Surname(s) First name()
Anca Maria Cimpean, MD, PhD
Name and
address of
employer
“VICTOR BABES” UNIVERSITY OF MEDICINE AND PHARMACY, PIATA EFTIMIE MURGU NR.2, 300041,
TIMISOARA, ROMANIA
Education and
training
2013- HABILITATION THESIS DISSERTATION
2010- PRESENT- SPECIALIST IN ANATOMIC PATHOLOGY
2004-2009- RESIDENCY IN ANATOMIC PATHOLOGY, “VICTOR BABES” UNIVERSITY OF MEDICINE AND
PHARMACY, DEPARTMENT OF HISTOLOGY AND CYTOLOGY, TIMISOARA, ROMANIA
2002-present: WORK IN IMMUNOHISTOCHEMISTRY LAB OF HISTOLOGY AND CYTOLOGY
DEPARTMENT, DEVELOPER OF SPECIAL SKILLS FOR AUTOMATED AND MANUAL
IMMUNOHISTOCHEMICAL PROCEDURES, ANTIBODIES STANDARDIZATION.
2008- PhD with SUMMA CUM LAUDE distinction based on DIPLOMA no. 50 from 21.04.2008 , VICTOR
BABES UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA ROMANIA and RESEARCH AND
EDUCATION MINISTRY PAPER no. 3439/12.03.2008.
2007-PhD THESIS DISSERTATION WITH DOCTORAL WORK ENTITLED „CHARACTERIZATION OF THE
MALIGNANT TUMORS ANGIOGENIC PHENOTYPE AND IT CLINICAL AND EXPERIMENTAL
MODULATION
2007-TRAINING IN EXPERIMENTAL METHODS-MEDICAL UNIVERSITY OF BARI, ITALY, PROFESSOR
DOMENICO RIBATTI
2002-2007- PhD STUDENT IN HISTOLOGY AND TUMOR ANGIOGENESIS, MEDICINE
1998-2002- RESIDENCY IN GENERAL PRACTICE MEDICINE
Principal
subjects/occupatio
nal skills covered
HISTOLOGY, PATHOLOGY, ELECTRON MICROSCOPY, GENERAL PRACTICE,
IMMUNOHISTOCHEMISTRY, MOLECULAR DIAGNOSTIC METHODS, EXPERIMENTAL MODELS
FOR TUMOR ANGIOGENESIS, MEDICAL EDUCATION FOR UNDERGRADUATE AND
POSTGRADUATE STUDENTS, PhD SUPERVISOR, MEDICAL WRITING, MEDICAL STUDENT
SUPERVISOR, TISSUE MICROARRAY TECHNIQUES, RNAscope and BASEscope METHODS,
Other language(s) ENGLISH, FRENCH, GERMAN
Technical skills
and compe
Electronic addresses
and IDs for research
profile evaluation
Fellowship, awards
and diplomas
RESIDENCY IN PATHOLOGY, ELECTRON MICROSCOPY, MOLECULAR BIOLOGY,
IMMUNOHISTOCHEMICAL AND OTHER LABORATORY TECHNIQUES., EXPERIMENTAL METHODS.
Results of these practical skills were recognized at the international scientific level by several citation of her
papers in Wikipedia (en.wikipedia.org/wiki/Keratin_34, en.wikipedia.org/wiki/Chorioallantoic_ membrane,
de.wikipedia.org/wiki/Thymus-Epithelzelle) and in the antibodies datasheets of numerous manufacturers from
Europe, Asia and USA,http://www.epitomics.com/products/product_
info/413,http://www.cellmarque.com/pdf_files/direct/1992.pdf,http://www.sinobiological.com/ VEGF-Protein-a-
229.html, http://www.abcam.com/Podoplanin-gp36-antibody-18H5- ab10288.html).
RESEARCHGATE account: https://www.researchgate.net/profile/Cimpean_Anca_Maria
researcherid.com profile: C-4094-2011, http://www.researcherid.com/rid/C-4094-2011 ,
ORCID ID: orcid.org/0000-0002-9530-022X, Scopus Author ID: 8627855900,
LINKEDIN profile: https://www.linkedin.com/in/anca-maria-cimpean-3b853152?trk=nav_responsive_tab_profile_pic
GOOGLE SCHOLAR: https://scholar.google.com/citations?hl=en&user=34bYy9wAAAAJ&view_op=list_works&sortby=pubdate
ACADEMIA.EDU: https://independent.academia.edu/AncaCimpean
PUBLONS profile: https://publons.com/researcher/1198198/anca-maria-cimpean/
FELLOWSHIP IN PATHOLOGY, SALZBURG CLEVELAND PATHOLOGY SEMINAR, May 2015
FELLOWSHIP IN PATHOLOGY, SALZBURG CLEVELAND PATHOLOGY SEMINAR, September 2016
AWARD FOR ACADEMIC EXCELLENCE, SALZBURG CLEVELAND PATHOLOGY SEMINAR, AUSTRIA,
September 2016
AWARD FOR EXCELLENT CASE PRESENTATION, SALZBURG CLEVELAND PATHOLOGY SEMINAR,
September 2016
AWARD FOR SCIENTIFIC RECOGNITION FOR ACADEMIC YEAR 2015, GIVEN BY RESEARCH
DEPARTMENT
OF “VICTOR BABES” UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA ROMANIA
Computer skills
and competences
Advanced level of computer use: WORD, POWERPOINT, EXCELL, STATISTICAL ANALYSIS, BITMAP,
JAMOVI, SPSS, J IMAGE,
Member of UEFISCDI evaluators GROUP as national evaluator for research projects: www.brainmap.ro
International evaluator of medical research projects for the following agencies: FECYT (ISRAEL), DLR and
ERANet-LAC (BARCELONA, SPAIN, BRUXELLES, BELGIUM), Based on evaluator certificate from 28.09.2016.
3. Page 3/20 - Curriculum vitae of
Surname(s) First name()
Anca Maria Cimpean, MD, PhD
H-index and Scores according with Web of Science, Scopus, Publons and Gooogle Scholar
Most relevant citations of the articles and scientific work of Anca Maria Cimpean in international
publications
CITATIONS in INTERNATIONAL BOOKS
1. Metastasis of Breast Cancer - Pag 256. Robert E. Mansel, Oystein Fodstad, Wen G. Jiang – 2009, SPRINGER,
2. Tumor Microenvironment - Pag 417, Dietmar W. Siemann – 2010, Wiley Blackwell
3. Urologic surgical pathology - Pag 378. David G. Bostwick, Liang Cheng – 2008, MOSBY, Elsevier
4. Pre-Invasive Disease: Pathogenesis and Clinical Management – Pag. 312, Rebecca C. Fitzgerald – 2010,
SPRINGER
5. Recent Developments In Computing And Its Applications, Pag 491, M. Afshar Alam, Tamanna Siddiqui, K.R.
Seeja – 2009, International Publishing House
6. Recent Advances in Angiogenesis and Antiangiogenesis, Pag 52, edited by Domenico Ribatti, 2009, Bentham
Science Publisher
7. Receptor Protein-Tyrosine Kinases: Advances in Research and ... - Page 183, Q Asthon Acton, Scholarly Editions,
2012
8. Cancer Stem Cells in Solid Tumors, pag. 457, edited by Alison L. Allan, 2011
9. Kallikrein-related peptidases: Characterization, regulation, and ...edited by Viktor Magdolen, Christian P.
Sommerhoff, Hans Fritz, Manfred Schmitt,
10. Paraneoplastic Syndromes, pag 268 By Robert B. Darnell, Jerome B. Posner, Oxford, University Press, 2011
11. Tumor Angiogenesis Regulators pag. 200,edited by Ruben R. Gonzalez-perez, Bo R. Rueda, 2013
12. Pathology of the Mediastinum - Page 100, edited by Alberto M. Marchevsky, Mark R. Wick, Cambridge University
Press, 2014
13. Diagnostic Immunohistochemistry, page 129, By David J Dabbs, Elsevier, Saunders, 2013
14. Rosai and Ackerman's Surgical Pathology 10e, by Juan Rosai, 2011
15. Essentials of Electrodiagnostic Medicine, By William W. Campbell, Demos Medical Publishing, 2013
16. Angiogenesis in Adipose Tissue - Page 126, By Yihai Cao, Springer, 2013
SCIENTIFIC WORK CITED ON INTERNATIONAL RECOGNIZED WEBSITES AND/OR IN PROTOCOLS
OF ANTIBODIES MANUFACTURERS
3.1.Keratin 34 - Wikipedia, the free encyclopedia: Raica M, Zylis D, Cîmpean AM (2007). "Cytokeratin 20, 34betaE12
and overexpression of HER-2/neu in urine cytology as predictors of recurrences in ...
en.wikipedia.org/wiki/Keratin_34
3.2.Chorioallantoic membrane - Wikipedia, the free encyclopedia
Cimpean AM, Ribatti D, Raica M (2008). "The chick embryo chorioallantoic membrane as a model to study tumor
metastasis". Angiogenesis 11 (4): 311–9. ...en.wikipedia.org/wiki/Chorioallantoic_membrane
3.3. Thymus-Epithelzelle – Wikipedia. Raica M, Encică S, Motoc A, Cîmpean AM, Scridon T, Bârsan M.: Structural
heterogeneity and immunohistochemical profile of Hassall corpuscles in normal human ...
de.wikipedia.org/wiki/Thymus-Epithelzelle
Research articles cited in protocols of various antibodies manufacturers:
4.1. EPITOMICS (USA)VEGFR-1 (N-term)antibody RabMAb®
Cimpean AM, Raica M, Encicab S, et al, Immunohistochemical expression of vascular endothelial growth factor A
(VEGF), and its receptors (VEGFR1, 2) in normal and pathologic conditions of the human thymus ,Ann Anat 190 (2008)
238-245 [Application: IHC]. http://www.epitomics.com/products/product_info/413
4.2. CELL MARQUE CORPORATION-USA, CD105 (Endoglin) (MRQ-14)
Annexes MOST REPRESENTATIVE LATEST PUBLICATIONS , CITATIONS AND CONTRIBUTION TO THE
DEVELOPMENT OF SCIENTIFIC RESEARCH IN ROMANIA AND ABROAD
4. Page 4/20 - Curriculum vitae of
Surname(s) First name()
Anca Maria Cimpean, MD, PhD
Cîmpean AM, Raica M, Suciu C. CD105/smooth muscle actin double immunostaining discriminate between immature
and mature tumor blood vessels. Rom J Morphol Embryol. 2007;48(1):41-
5.http://www.cellmarque.com/pdf_files/direct/1992.pdf
4.3. SINO BIOLOGICALS (China)VEGF Protein (VEGF A Protein)
Cimpean AM, et al. (2008) Vascular endothelial growth factor A (VEGF A) as individual prognostic factor in invasive
breast carcinoma. Rom J Morphol Embryol. 49(3): 303-8. http://www.sinobiological.com/VEGF-Protein-a-229.html
4.4. ABCAM (United Kingdom) Podoplanin / gp36 antibody [18H5] http://www.abcam.com/Podoplanin-gp36-antibody-
18H5-ab10288.html
Address of the researcherid.com profile: C-4094-2011, http://www.researcherid.com/rid/C-4094-2011
MEMBER OF :
1.ANGIOGENESIS RESEARCH CENTER TIMIŞOARA, www.angiotm.com
2.ROMANIAN SOCIETY OF NORMAL AND PATHOLOGY MORPHOLOGY
3.EUROPEAN SOCIETY OF MEDICAL ONCOLOGY
4. ROMANIAN ASSOCIATION OF SCIENTIFIC EDITORS
5.EUROPEAN ASSOCIATION OF SCIENTIFIC EDITORS
6.NATIONAL CENTER OF VASCULAR MALFORMATIONS TIMISOARA, ROMANIA
EDITORIAL BOARD MEMBER OF THE FOLLOWING JOURNALS:
1.WORLD JOURNAL OF RESPIROLOGY
2.RESEARCH AND CLINICAL MEDICINE.
3.JOURNAL OF PHARMACOLOGICAL RESEARCH
4.AMERICAN JOURNAL OF HUMAN PATHOLOGY.
5.AMERICAN JOURNAL OF EXPERIMENTAL BIOLOGY
6.JOURNAL OF DISEASE MARKERS
7.ADVANCES IN ANATOMY
8.APERITO JOURNAL OF CELLULAR AND MOLECULAR BIOLOGY
9.AUSTIN BIOMARKERS AND DIAGNOSIS
10. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
RESEARCH GRANTS INVOLVEMENT AS DIRECTOR OR PARTICIPANT
P1. Cîmpean Anca Maria- participant, expert categoria B preclinical field. Quality and european professional competence
in medical education and educational activities management. Project leader: Marius Raica, No. 63815, AMPOSDRU:
E9781/20.12.2010., Amount 2.000.000 Euro, 2010-2013.
P2. Cîmpean Anca Maria – project manager. Molecualr assessement of breast cancer and identification of new therapeutic
targets. PN II IDEI, 1147/2009, Amount: 240.000 Euro, 2009-2011.
P3. Cîmpean Anca Maria- participant. Chemokine profiles correlated with tumor phenotype, metastatic status and
development of resistance to therapy in breast cancer. Idei 1197/2009.
P4. Cimpean Anca Maria- project manager. Mobilites fellow. CNCSIS, Human resources, 222/2009. Amount: 1500 Euro,
2009
P5. Cîmpean Anca Maria- participant. Prognostic and therapeutic value of tumor lymphangiogenesis. Clinico pathologic and
experimental study in malignant solid tumors. PNII/Parteneriate, Cod 41-054/2007, Amount: 500.000 Euro, 2007-2010.
P6. Cîmpean Anca Maria- participant. Laborator for breast cancer molecular diagnosis. PNII/Capacitati, Cod 96/2007,
Amount: 500000 Euro, 2007-2009.
P7. Cîmpean Anca Maria- participant. The effects of pro and anti mast cells degranulations agents against tumor
angiogenesis. CNCSIS 2006, Cod 759/2006:Amount: 35.000 Euro, 2006-2008
P8. Cîmpean Anca Maria- participant. Endoscopic, histologic, immunologic and immunohistochemical monitoring of
premalignant gastric lesions and characterisation of early stages of malignant invasion in gastric cancer. CEEX
190/2006.Amount P1: 35.000 Euro, 2006-2008
P9. Cîmpean Anca Maria-participant. Angiogenic phenotype of malignant tumors. Clinicopathologic and experimental study.
1193/2004. 100.000 Euro, 2004-2006
P10. Cîmpean Anca Maria-participant. Expression and clinical significance of prostate specific antigen correlated with
hormone receptors levels and HER2/neu protein in breast cancer. VIASAN. Cod proiect: 029/2004. Amount : 500.000 Euro,
2004-2006.
P 11. Cimpean Anca Maria-project manager. Angiogenesis and lymphangiogenesis in primary human pterygium and its
recurrences as potential therapeutic target. TE 109/2011, UEFISCDI, Amount 117.000 Euro, 2011-2013
P 12. Cîmpean Anca Maria-participant. Lymphangiogenesis in molecular types of breast cancer as a prerequisite for their
metastasis. 500.000 Euro, 2011-2015.
TIMIŞOARA, 15..09.2020 ANCA MARIA CÎMPEAN, MD, PhD,Hab.Dr.
Full Professor of Histology
Pathologist
5. Page 5/20 - Curriculum vitae of
Surname(s) First name()
Anca Maria Cimpean, MD, PhD
LIST OF PUBLICATIONS
I. PhD Thesis Title
1. Characterisation of the angiogenic phenotype of malignant tumors and its
modulation in clinical and experimental conditions. Coordinator:Prof. Dr. Marius
Raica. Dissertation date: 6.07.2007 , Confirmed: 12.03.2008.
II. Habilitation thesis.
1. The molecular profile of tumor and non tumor associated angiogenesis and
lymphangiogenesis.Impact on targeted therapy. Dissertation: October, 4th 2013,
Confirmed: November, 28th, 2013
III. Books and Book Chapters
III.1. National books recognized by CNCSIS.
1. Marius Raica, Anca Maria Cîmpean, Puşa Gaje, Domenico Ribatti. Angiogeneza şi limfangiogeneza tumorală.
Editura “Victor Babeş” Timişoara, ISBN 978-606-8054-28-5, 2010
2. Scridon T., Encică S, Cîmpean AM, Raica M, Bârsan M. Patologia Timusului. Editura Medicală Universitară “Iuliu
Haţieganu” Cluj Napoca, ISBN 978-973-693-305-9, 2009
3. Narita D, Raica M, Cimpean AM, Anghel A. Markeri tumorali in cancerul de sin, Editura Eurobit Timisoara,ISBN
978-973-620-315-2, 2007
III.2. Book chapters published in international books
1. Raica M, Cimpean AM. Thymus and angiogenesis in Recent advances in angiogenesis and antiangiogenesis,
Bentham Publisher,USA, eISSN 978-1-60805-004-8, 2009.
2. Sarb S, Raica M , Cimpean AM. Human Embryonic Blood Vessels: What Do They Tell Us About Vasculogenesis
and Angiogenesis? Vasculogenesis and Angiogenesis - from Embryonic Development to Regenerative Medicine .
Publisher: InTech , ISBN 978-953-307-882-3, 2011
3. Cimpean AM, Mazuru V, Şaptefraţi L, Raica M. Shadow Keyplayers of the Uterine Cervix Lesions Progression
and Metastasis. Histopathology-Reviews and Recent Advances Publisher: InTechOpen, Editor Enrique Poblet
Martinez, ISBN 978-953-51-0866-5, 2012
4. Cimpean AM, Ribatti D, Raica M. A Historical Appraisal of Angiogenesis Assays since Judah Folkman and
Before...Chapter 2 In „Angiogenesis: Insights from a Systematic Overview”, ISBN: 978-1-62618-114-4, Editor
Gaetano Santulli (Columbia University Medical Center, College of Physicians & Surgeons, Columbia University,
New York, NY, USA), Series: Cell Biology Research Progress from NOVASCIENCE PUBLISHER, NEW YORK,
2013
5. Cimpean AM, Sava-Poenaru M, Raica M. Angiogenesis and Lymphangiogenesis as Molecular Therapeutic
Targets in Human Pterygium And Its Recurrences. Chapter 10 in „Angiogenesis: Insights from a Systematic
6. Page 6/20 - Curriculum vitae of
Surname(s) First name()
Anca Maria Cimpean, MD, PhD
Overview”, ISBN: 978-1-62618-114-4, Editor Gaetano Santulli (Columbia University Medical Center, College of
Physicians & Surgeons, Columbia University, New York, NY, USA), Series: Cell Biology Research Progress from
NOVASCIENCE PUBLISHER, NEW YORK, 2013
6. Laurențiu Pirtea, Andreea Adriana Jitariu, Marius Raica, Anca Maria Cimpean. Angiogenesis and
lymphangiogenesis in ovarian cancer. Lessons from the lab to the clinic. LAP LAMBERT Academic
Publishing. 2015. ISBN: 978-3-659-80103-7
7. Oprea M, Cimpean AM, Poenaru DV, Raica M. NERVE STRUCTURES INSIDE THE INTERVERTEBRAL DISC: A POSSIBLE
LINK TO SYMPTOMATIC LUMBAR DISC DISEASE.Book Title: Intervertebral Disc Degeneration: Prevalence, Risk Factors
and Treatments, NovaScience Publisher New York, 2016
2015-2019 RELEVANT PUBLICATIONS ACCORDING WITH GOOGLE SCHOLAR AND WEB OF SCIENCE (in
extenso, abstracts conferences, book chapters)
1. Is Circular Fibrin Sealing of Low Rectal Anastomosis Able to Prevent Leakage in 21-Day Follow-up? Randomized
Experimental Trial in Pigs. FA Wenger, E Szucsik, BF Hoinoiu, AM Cimpean, JP Matonick, M Ionac, Surgical
Innovation 26 (4), 408-419, 2019
2. D Taran, VN Tarlui, RA Ceausu, AM Cimpean, M Raica, S Sarb. Podoplanin and PROX1 Expression in Hypercaloric
Diet-induced Pancreatic Injuries In vivo 33 (4), 1157
3. A Nesiu, AM Cimpean, RA Ceausu, A Adile, I Ioiart, C Porta, M Mazzanti, ... Intracellular chloride ion channel protein-
1 expression in clear cell renal cell carcinoma. Cancer Genomics-Proteomics 16 (4), 299-3074, 2019
4. A Militaru, S Zus, AM Cimpean, S Iurciuc, P Matusz, M Iurciuc, D Lighezan, ... Early Diagnosis of Cardiotoxicity in
Patients Undergoing Chemotherapy for Acute Lymphoblastic Leukemia. Anticancer research 39 (6), 3255-3264, 2019
5. E Carpenco, RA CEAUŞU, AM Cimpean, PN Gaje, L ȘAPTEFRAŢI, ... Mast cells as an indicator and prognostic
marker in molecular subtypes of breast cancer. In vivo 33 (3), 743-748, 2019
6. EJM Huijbers, IM Van Der Werf, LD Faber, LD Sialino, P Van Der Laan, ... Targeting tumor vascular CD99 inhibits
tumor growth. Frontiers in Immunology 10, 651, 2019
7. AS Corlan, AM Cîmpean, E Melnic, M Raica, S Sarb. VEGF, VEGF165b and EG-VEGF expression is specifically
related with hormone profile in pituitary adenomas. European Journal of Histochemistry: EJH 63 (1), 2019
8. C Capatina, AM Cimpean, M Raica, M Coculescu, C Poiana. SOX 2 Expression in Human Pituitary Adenomas–
Correlations With Pituitary Function. In vivo 33 (1), 79-83, 2019
9. L Cirligeriu, AM Cimpean, H Calniceanu, M Vladau, S Sarb, M Raica, ... Hyaluronic acid/bone substitute complex
implanted on chick embryo chorioallantoic membrane induces osteoblastic differentiation and angiogenesis, but not
Inflammation. International Journal of Molecular Sciences 19 (12), 4119, 2018
10. VLJL Thijssen, YWJ Paulis, P Nowak-Sliwinska, KL Deumelandt, ... Targeting PDGF-mediated recruitment of
pericytes blocks vascular mimicry and tumor growth. The Journal of Pathology 246 (4), 447-458, 2018
11. A Militaru, A Avram, AM Cimpean, M Iurciuc, P Matusz, D Lighezan, ... The assessment of left ventricle function and
subclinical atherosclerosis in patients with acute myeloid leukemia. In vivo 32 (6), 1599-1607, 2018
12. AA Jitariu, M Raica, AM Cîmpean, SC Suciu. The role of PDGF-B/PDGFR-BETA axis in the normal development and
carcinogenesis of the breast. Critical Reviews in Oncology/Hematology 131, 46-528201836th
13. S Di Carlo, F De Angelis, E Brauner, D Rosella, P Papi, G Pompa, ... Histological and immunohistochemical evaluation
of mandibular bone tissue regeneration. International Journal of Immunopathology and Pharmacology 32,
2058738418798249, 2018
14. R Heredea, AM Cimpean, S Cerbu, CM Popoiu, AA Jitariu, M Raica. New approach to rare pediatric multicystic
mesenteric lymphangioma; would it guide the development of targeted therapy? Frontiers in Pediatrics 6, 223, 2018
15. P Nowak-Sliwinska, K Alitalo, E Allen, A Anisimov, AC Aplin, R Auerbach, ... Consensus guidelines for the use and
interpretation of angiogenesis assays. Angiogenesis 21 (3), 425-532, 2018
16. AM Cimpean, D LALOŠEVIĆ, V Lalošević, P Banović, M Raica, ... Disodium cromolyn and anti-podoplanin antibodies
strongly inhibit growth of BHK 21/C13-derived fibrosarcoma in a chick embryo chorioallantoic membrane model. In
vivo 32 (4), 791-798, 2018
17. AR Ceausu, A Ciolofan, AM Cimpean, A Magheti, O Mederle, M Raica. The Mesenchymal–Epithelial and Epithelial–
Mesenchymal Cellular Plasticity of Liver Metastases with Digestive Origin. Anticancer research 38 (2), 811-816, 2018
18. A Cioca, D Muntean, C Bungardean, M Raica, AM Cimpean. Expression and distribution of galectin-3 in chromophobe
and papillary carcinomas. Anticancer Research 38 (1), 259-263,2018
19. IS Bujor, A Cioca, RA CEAUȘU, F Veaceslav, C Nica, AM Cimpean, ... Evaluation of vascular proliferation in
molecular subtypes of breast cancer. In vivo 32 (1), 79-83,2018
20. Ş COMŞA, RA CEAUȘU, R Popescu, AM Cimpean, M Raica. The human mesenchymal stem cells and the chick
embryo chorioallantoic membrane: the key and the lock in revealing vasculogenesis. In vivo 31 (6), 1139-1144,2017
21. AA Jitariu, AC Toma, AM Cimpean, M Raica. Refining the accuracy of primary and metastatic breast cancer diagnosis:
An immunohistochemical assessment of myoeptithelial cells following tissue microarray (TMA) application.
VIRCHOWS ARCHIV 471, S296-S296,2017
22. A Cioca, AM Cimpean, RA Ceausu, V Tarlui, A Toma, I Marin, M Raica. Evaluation of Podoplanin Expression in
Hepatocellular Carcinoma Using RNAscope and Immunohistochemistry–A Preliminary Report. Cancer Genomics-
Proteomics 14 (5), 383-387, 2017
23. AM Cimpean, V Tarlui, AA CUMPĂNAŞ, S Bolintineanu, A CUMPĂNAŞ, ... Critical Overview of HER2 Assessement
in Bladder Cancer: What Is Missing for a Better Therapeutic Approach? Anticancer Research 37 (9), 4935-4942, 2017
24. AA Jitariu, AM Cîmpean, D Ribatti, M Raica. Triple negative breast cancer: the kiss of death. Oncotarget 8 (28),
46652, 2017
25. AM Cimpean, R Tamma, S Ruggieri, B Nico, A Toma, D Ribatti. Mast cells in breast cancer angiogenesis. Critical
Reviews in Oncology/Hematology 115, 23-26, 2017
7. Page 7/20 - Curriculum vitae of
Surname(s) First name()
Anca Maria Cimpean, MD, PhD
26. M Raica, AM Cimpean. Paul Langerhans: hodočasnik koji je" putovao" of funkcionalne histologije do biologije mora.
Paul Langerhans: a prilgrim" traveling" from functional histology to marine biology. Acta medico-historica Adriatica 15
(1), 139-1462017
27. AS Corlan, A Cimpean, M Raica, E Melnic, RA Ceausu. HER2, EGFR and PDGF family members as potential
prognostic markers and their therapeutic implications. 19th European Congress of Endocrinology 49, 2017
28. B Bălinişteanu, AM Cîmpean, AR Ceauşu, AS Corlan, E Melnic, M Raica High Ki-67 expression is associated with
prolactin secreting pituitary adenomas. Bosnian Journal of Basic Medical Sciences 17 (2), 104,2017
29. AS Corlan, AM Cîmpean, AA Jitariu, E Melnic, M Raica. Endocrine gland-derived vascular endothelial growth
factor/prokineticin-1 in cancer development and tumor angiogenesis. International Journal of Endocrinology 2017
30. S Comsa, R Popescu, S Avram, RA Ceausu, AM Cimpean, M Raica. Bevacizumab Modulation of the Interaction
Between the MCF-7 Cell Line and the Chick Embryo Chorioallantoic Membrane. In Vivo 31 (2), 199-203, 2017
31. A Cioca, AR Ceausu, I Marin, M Raica, AM Cimpean. The multifaceted role of podoplanin expression in hepatocellular
carcinoma. European Journal of Histochemistry: EJH 61 (1),2017
32. F Veaceslav, CA Raluca, CA Maria, S Lilian, R Marius. B-cell lymphoma-2 receptor in human primary breast and its
lymph node metastases: more than a surrogate marker. The Moldovan Medical Journal 60 (1),2017
33. S Iurciuc, AM Cimpean, F Mitu, R Heredea, M Iurciuc. Vascular aging and subclinical atherosclerosis: why such a
“never ending” and challenging story in cardiology?. Clinical Interventions in Aging 12, 1339, 2017
34. AM Cimpean, AR Ceausu, A Corlan, E Melnic, AA Jitariu, M Raica. The “game” of glial fibrillary acidic and S100
proteins in pituitary adenomas: two players or several? Endokrynologia Polska 68 (4), 380-389, 2017
35. AM Cimpean, M Raica. The hidden side of disodium cromolyn: from mast cell stabilizer to an angiogenic factor and
antitumor agent. Archivum immunologiae et therapiae experimentalis 64 (6), 515-522, 2016
36. AM Cimpean, IM Cobec, RA CEAUȘU, R Popescu, A Tudor, M Raica. Platelet derived growth factor BB: a “Must-
have” therapeutic target “redivivus” in ovarian cancer. Cancer Genomics-Proteomics 13 (6), 511-517,2016
37. IM Cobec, I Sas, L PIRTEA, AM Cimpean, AE Moatar, RA CEAUȘU, ... Podoplanin as key player of tumor progression
and lymph vessel proliferation in ovarian cancer. Anticancer research 36 (10), 5265-5272, 2016
38. AA Jitariu, AM Cimpean, AR Ceausu, E Melnic, M Raica. From breast to" endocrine brain": The heterogeneous
expression of ErbB family members in pituitary adenomas. VIRCHOWS ARCHIV 469 (SUPPL 1), S75-S75, 2016
39. B Balinisteanu, AM Cimpean, AR Ceausu, M Raica. Gastrointestinal Stromal Tumour (GIST) of an obliterated
vermiform appendix: A case report. VIRCHOWS ARCHIV 469 (SUPPL 1), S267-S267, 2016
40. B Balinisteanu, AM Cimpean, AR Ceausu, E Melnic, AS Corlan, M Raica Vascular Endothelial Growth Factor (VEGF)
and its inhibitory isoform VEGF165b: Dual role in pituitary adenomas. VIRCHOWS ARCHIV 469 (SUPPL 1), S175-
S175, 2016
41. AA Jitariu, AM Cimpean, AR Ceausu, E Melnic, M Raica. GFAP and S100 protein game in pituitary adenomas: Single
player or multiplayer configuration? VIRCHOWS ARCHIV 469 (SUPPL 1), S75-S76, 2016
42. M Raica, AA Jitariu, AM Cimpean. Lymphangiogenesis and anti-lymphangiogenesis in cutaneous melanoma.
Anticancer Research 36 (9), 4427-4435,2016
43. S Iurciuc, C Avram, V Turi, A Militaru, A Avram, AM Cimpean, M Iurciuc. Physical training, hemodynamic parameters
and arterial stiffness: friends or foes of the hypertensive patient? In vivo 30 (4), 521-528, 2016
44. MM Margan, AA Jitariu, AM Cimpean, C Nica, M Raica Molecular portrait of the normal human breast tissue and its
influence on breast carcinogenesis. Journal of Breast Cancer 19 (2), 99-111,2016
45. AA CUMPĂNAS, AM Cimpean, O Ferician, RA Ceausu, S Sarb, V Barbos, ... The involvement of PDGF-B/PDGFRβ
axis in the resistance to antiangiogenic and antivascular therapy in renal cancer. Anticancer Research 36 (5), 2291-
229, 2016
46. Ferician, AM Cimpean, AR Ceausu, A Dema, M Raica, A Cumpanas. Heterogeneous vascular patterns in renal cell
carcinomas. Polish Journal of Pathology 67 (1), 46-53, 2016
47. MD Oprea, AM Cimpean, M Raica, DV Poenaru NERVE STRUCTURES INSIDE THE INTERVERTEBRAL DISC:
APOSSIBLE LINK TO SYMPTOMATIC LUMBAR DISC DISEASE. INTERVERTEBRAL DISC DEGENERATION, 17,
2016
48. V Fulga, AR Balica, AM Cîmpean, L Șaptefrați, M Raica. Expression of CK5 basal cytokeratin during metastatic
development of breast carcinoma. Research and Clinical Medicine 1 (1), 15-21, 2016
49. RA Ceauşu, AM Cîmpean, P Gaje, M Raica, Overexpression of VEGF and VEGFR2 in chronic hepatitis and liver
cirrhosis. Angiogenesis: prezent and future, 40, 2016
50. AM Cîmpean, E Melnic, A Corlan, AR Ceaușu, M Raica. HETEROGENEITY OF C ERB B FAMILY MEMBERS
EXPRESSION IS RELATED TO CELL MORPHOLOGY AND IMMUNOPROFILE IN PITUITARY ADENOMAS.
Research and clinical medicine. The European Journal of Innovative …12016
51. DE Coricovac, I Pinzaru, IZ Pavel, R Ghiulai, AM Cimpean, C Soica, ... Experimental models of human melanoma.
Toxicology Letters, S93,2016
52. M Vladau, AM Cimpean, RA Balica, AA Jitariu, RA Popovici, M Raica. VEGF/VEGFR2 axis in periodontal disease
progression and angiogenesis: basic approach for a new therapeutic strategy. In Vivo 30 (1), 53-60, 2016
53. AM Cimpean, RA Balica, IC Doros, NC Balica, PN Gaje, RA Popovici, ... Epidermal growth factor receptor (EGFR)
and keratin 5 (K5): versatile keyplayers defining prognostic and therapeutic sub-classes of head and neck squamous
cell carcinomas. Cancer Genomics-Proteomics 13 (1), 75-81,2016
54. Ferician, AM Cimpean, S Avram, M Raica. Endostatin effects on tumor cells and vascular network of human renal
cell carcinoma implanted on chick embryo chorioallantoic membrane. Anticancer Research 35 (12), 6521-6528, 2015
55. AM Cimpean, M Raica. Lymphangiogenesis and Inflammation—Looking for the “Missing Pieces” of the Puzzle.
Archivum Immunologiae et Therapiae Experimentalis 63 (6), 415-426,2015
56. SE GIUŞCĂ, ID CĂRUNTU, AM Cimpean, RE Avadanei, AR Balica, ... Tryptase-positive and CD117 positive mast
cells correlate with survival in patients with liver metastasis. Anticancer research 35 (10), 5325-5331, 2015
57. AR Balica, E Boia, PN Gaje, AM Cimpean, M Raica. Epidermal Growth Factor Receptor (EGFR) and p53 co-
expression in Head and Neck Squamous Cell Carcinomas (SCC). VIRCHOWS ARCHIV 467, S88-S88, 2015
58. AM Cimpean, NC Balica, CI Doros, M Raica. Interplay between Epidermal Growth Factor Receptor (EGFR), Keratin
5 (K5) and TNM staging parameters in Head and Neck Squamous Cell Carcinomas (SCC). VIRCHOWS ARCHIV
467, S26-S26, 2015
59. S Comsa, S Avram, AR Balica, AM Cimpean, M Raica. The MCF-7 breast cancer cell line and the chick chorioallantoic
membrane. How does bevacizumab modulate this interaction? VIRCHOWS ARCHIV 467, S12-S12, 2015
60. AM Cimpean, E Melnic, B Balinisteanu, M Coculescu, M Raica, E Foca. Comparative assessement of hormone
immunoprofile between pituitary adenomas coming from Romania and Republic of Moldova. VIRCHOWS ARCHIV
467, S73-S74, 2015
8. Page 8/20 - Curriculum vitae of
Surname(s) First name()
Anca Maria Cimpean, MD, PhD
61. SE Giusca, R Avadanei, ID Caruntu, DG Ciobanu, M Raica, AM Cimpean. Tryptase positive mast cells in colorectal
liver metastases. VIRCHOWS ARCHIV 467, S232-S232, 2015
62. B Balinisteanu, AM Cimpean, AR Balica, E Melnic, AS Corlan, M Raica. Platelet-derived Growth Factor (PDGF) A
and PDGF B/PDGFR beta axis in pituitary adenomas. VIRCHOWS ARCHIV 467, S212-S212, 2015
63. AA Jitariu, DS Goldis, AM Cimpean, M Raica. Comparative assessment of CD34 and Endoglin (CD105) positive
tumour blood vessels from rectal cancer: Correlation with biological and histopathological parameters. VIRCHOWS
ARCHIV 467, S191-S191, 2015
64. FA Wenger, E Szucsik, BF Hoinoiu, AM Cimpean, M Ionac, M Raica. Circular anastomotic experimental fibrin sealant
protection in deep colorectal anastomosis in pigs in a randomized 9-day survival study. International Journal of
Colorectal Disease 30 (8), 1029-1039,2015
65. L Lozneanu, R Avadanei, AM Cîmpean, SE Giusca, C Amalinei, ... Relationship between the proangiogenic role of
EG-VEGF, clinicopathological characteristics and survival in tumoral ovary. The Medical-Surgical Journal 119 (2),
460-465,2015
66. Ş Comşa, AM Cimpean, M Raica. The story of MCF-7 breast cancer cell line: 40 years of experience in research.
Anticancer research 35 (6), 3147-3154, 2015
67. C Danciu, C Oprean, DE Coricovac, C Andreea, A Cimpean, H Radeke, ... Behaviour of four different B 16 murine
melanoma cell sublines: C57 BL/6J skin. International Journal of Experimental Pathology 96 (2), 73-80, 2015
68. AA Jitariu, AM Cimpean, NR Kundnani, M Raica. Platelet-derived growth factors induced lymphangiogenesis:
evidence, unanswered questions and upcoming challenges. Archives of medical science: AMS 11 (1), 57, 2015
69. V Fulga, L Rudico, AR Balica, AM Cimpean, L Saptefrati, M Raica. Invasive ductal carcinoma of no special type and
its corresponding lymph node metastasis: do they have the same immunophenotypic profile? Polish Journal of
Pathology 66 (1), 30-37, 2015
70. V Fulga, L Rudico, AR Balica, AM Cimpean, L Saptefrati, MM Margan, .. Differential expression of E-cadherin in
primary breast cancer and corresponding lymph node metastases. Anticancer research 35 (2), 759-765, 2015
71. BA Raluca, AM Cimpean, A Cioca, O Cretu, O Mederle, A Ciolofan, ... Endothelial cell proliferation and vascular
endothelial growth factor expression in primary colorectal cancer and corresponding liver metastases. Asian Pac J
Cancer Prev 16 (11), 4549-4553, 2015
72. AM Cimpean, E Melnic, B Bălinişteanu, A Corlan, M Coculescu, S Rusu, ... Geographic-related differences of pituitary
adenomas hormone profile: analysis of two groups coming from southeastern and eastern Europe. International
Journal of Endocrinology 2015
73. M Raica, AM Cimpean, RA Popovici, AR Balica, M Vladau, PN Gaje. Mast cells stimulate lymphangiogenesis in the
gingiva of patients with periodontal disease. In Vivo 29 (1), 29-34,2015
74. M Oprea, I Popa, AM Cimpean, M Raica, DV Poenaru. Microscopic assessment of degenerated intervertebral disc:
clinical implications and possible therapeutic challenge.In vivo 29 (1), 95-102.
2011_2014 RELEVANT PUBLICATIONS:
1. Cimpean AM, Mazuru V, Cernii A, Ceausu R, Saptefrati L, Cebanu A, Fit AM, Raica M. Detection of early
lymphangiogenesis by lymphatic microvascular density and endothelial proliferation status in preneoplastic and
neoplastic lesions of the uterine cervix. Pathol Int. 2011 Jul;61(7):395-400. doi: 10.1111/j.1440-1827.2011.02673.x.
Epub 2011 Jun 13.
2. Cimpean AM, Poenaru Sava M, Raica M, Ribatti D. Preliminary evidence of the presence of lymphatic vessels
immunoreactive for D2-40 and Prox-1 in human pterygium. Oncol Rep. 2011 Jun 8. doi: 10.3892/or.2011.1342
3. Ceauşu RA, Cîmpean AM, Gaje P, Gurzu S, Jung I, Raica M. CD105÷Ki67 double immunostaining expression in liver
metastasis from colon carcinoma. Rom J Morphol Embryol. 2011;52(2):613-6.
4. Cimpean AM, Ceauşu R, Encică S, Gaje PN, Ribatti D, Raica M. Platelet-derived growth factor and platelet-derived
growth factor receptor-α expression in the normal human thymus and thymoma. Int J Exp Pathol. 2011 Jun 7. doi:
10.1111/j.1365-2613.2011.00777.x.
5. Raica M, Cimpean AM, Ceausu R, Ribatti D. Lymphatic microvessel density, VEGF-C, and VEGFR-3 expression in
different molecular types of breast cancer. Anticancer Res. 2011 May;31(5):1757-64.
6. Cimpean AM, Ribatti D, Raica M. A brief history of angiogenesis assays. Int. J. Dev. Biol. 2011 ;55(4-5):377-82
7. Duşe AO, Ceauşu RA, Mezei T, Cîmpean AM, Gaje P, Ioniţă H, Jung I. Mast cells contribute to the angiogenesis in
non-Hodgkin lymphoma. An immunohistochemical study based on the relationship with microvessel density. Rom J
Morphol Embryol. 2011;52(3 Suppl):1091-6.
8. Pirtea L, Raica M, Cimpean AM. Endothelial cell activation and proliferation in ovarian tumors: two distinct steps as
potential markers for antingiogenic therapy response. Mol Med Rep. 2012 May;5(5):1181-4
9. Ribatti D, Nico B, Cimpean AM, Raica M, Crivellato E, Ruggieri S, Vacca A. B16-F10 melanoma cells contribute to the
new formation of blood vessels in the chick embryo chorioallantoic membrane through vasculogenic mimicry. Clin Exp
Med. 2012 Apr 19.
10. Feflea S, Cimpean AM, Ceausu RA, Gaje P, Raica M. Effects of antibodies to EG-VEGF on angiogenesis in the chick
embryo chorioallantoic membrane. In Vivo. 2012 Sep-Oct;26(5):793-7.
11. Bălu S, Pirtea L, Gaje P, Cîmpean AM, Raica M. The immunohistochemical expression of endocrine gland-derived-
VEGF (EG-VEGF) as a prognostic marker in ovarian cancer. Rom J Morphol Embryol. 2012;53(3):479-83.
12. Cornea R, Cîmpean AM, Simu M, Cornea A, Suciu C, Raica M. Clinical, morphological and immunohistochemical
characterization of a recurrent B1 type thymoma. Rom J Morphol Embryol. 2012;53(3):639-43.
9. Page 9/20 - Curriculum vitae of
Surname(s) First name()
Anca Maria Cimpean, MD, PhD
13. Gurzu S, Cimpean AM, Kovacs J, Jung I. Counting of angiogenesis in colorectal carcinomas using double immunostain.
Tumori. 2012 Jul-Aug;98(4):485-90.
14. Cimpean AM, Mazuru V, Saptefrati L, Ceausu R, Raica M. Prox 1, VEGF-C and VEGFR3 expression during cervical
neoplasia progression as evidence of an early lymphangiogenic switch. Histol Histopathol. 2012 Dec;27(12):1543-50.
15. Birau A, Ceausu RA, Cimpean AM, Gaje P, Raica M, Olariu T Assessement of angiogenesis reveals blood vessel
heterogeneity in lung carcinoma. Oncol Lett. 2012 Dec;4(6):1183-1186.
16. Duşe AO, Ceauşu RA, Mezei T, Cîmpean AM, Gaje P, Ioniţă H, Jung I, Raica M. The characterization of PDGFR-alpha
and PDGFR-beta expression in malignant non-Hodgkin lymphoma. Rom J Morphol Embryol. 2012;53(3 Suppl):749-53.
17. Ceausu RA, Cimpean AM, Dimova I, Hlushchuk R, Djonov V, Gaje PN, Raica M. Everolimus dual effects of an area
vasculosa angiogenesis and lymphangiogenesis. In Vivo. 2013 Jan-Feb;27(1):61-6.
18. Duşe AO, Ceauşu RA, Cîmpean AM, Ioniţă H, Raica M, Gaje P. Heterogeneity of malignant non-Hodgkin lymphoma-
associated blood vessels. Rom J Morphol Embryol. 2012;53(4):985-8.
19. Avram SF, Cimpean AM, Raica M. Behavior of the P1.HTR mastocytoma cell line implanted in the chorioallantoic
membrane of chick embryos. Braz J Med Biol Res. 2013 Jan 11;46(1):52-7
20. Cimpean AM, Sava MP, Raica M. DNA damage in human pterygium: One-shot multiple targets. Mol Vis. 2013;19:348-
56.
21. Dehelean CA, Feflea S, Gheorgheosu D, Ganta S, Cimpean AM, Muntean D, Amiji MM. Anti-angiogenic and anti-
cancer evaluation of betulin nanoemulsion in chicken chorioallantoic membrane and skin carcinoma in Balb/c mice. J
Biomed Nanotechnol. 2013 Apr;9(4):577-89.
22. Cimpean AM, Raica M. Intranodal hemorrhagic spindle cell tumor with amianthoid fibers - report of a case with
emphasis to mast cell reaction and d2-40 expression. In Vivo. 2013 May-Jun;27(3):395-9.
23. Doroş C, Balica N, Cîmpean AM. Dendritic cells: friends or foes of laryngeal cancer? Rom J Morphol Embryol.
2013;54(1):131-5.
24. Stoia-Djeska I, Ceauşu RA, Cîmpean AM, Nicodin A, Tudorache V, Raica M.From basic lesions to a pathological
staging of pulmonary fibrosis. Rom J Morphol Embryol. 2013;54(1):63-9.
25. Raica M, Cimpean AM, Ceausu R, Ribatti D, Gaje P. Interplay between mast cells and lymphatic vessels in different
molecular types of breast cancer. Anticancer Res. 2013 Mar;33(3):957-63.
26. Gaje PN, Stoia-Djeska I, Cimpean AM, Ceausu RA, Tudorache V, Raica M. Lymphangiogenesis as a prerequisite in
the pathogenesis of lung fibrosis. In Vivo. 2014 May-Jun;28(3):367-73.
27. Cîrligeriu L, Cimpean AM, Raica M, Doroş CI. Dual role of podoplanin in oral cancer development. In Vivo. 2014 May-
Jun;28(3):341-7.
28. Raica M, Cîmpean AM, Ceausu RA, Fulga V, Nica C, Rudico L, Saptefrati L. Hormone receptors and HER2 expression
in primary breast carcinoma and corresponding lymph node metastasis: do we need both? Anticancer Res. 2014
Mar;34(3):1435-40.
29. Cîrligeriu L, Cimpean AM, Raica M, Doroş CI. Dual role of podoplanin in oral cancer development. In Vivo. 2014 May-
Jun;28(3):341-7
30. Gaje PN, Stoia-Djeska I, Cimpean AM, Ceausu RA, Tudorache V, Raica M. Lymphangiogenesis as a prerequisite in
the pathogenesis of lung fibrosis. In Vivo. 2014 May-Jun;28(3):367-73.
31. Cimpean AM, Crăiniceanu Z, Mihailovici D, Bratu T, Raica M. Human conchal cartilage and temporal fascia: an
evidence-based roadmap from rhinoplasty to an in vivo study and beyond. In Vivo. 2014 Jul-Aug;28(4):505-14.
32. Taban O, Cimpean AM, Raica M, Olariu S. PROX1 expression in gastric cancer: from hypothesis to evidence.
Anticancer Res. 2014 Jul;34(7):3439-46.
33. Globa T, Saptefrţi L, Ceauşu RA, Gaje P, Cimpean AM, Raica M. Mast cell phenotype in benign and malignant tumors
of the prostate. Pol J Pathol. 2014 Jun;65(2):147-53.
34. Bălinişteanu B, Cimpean AM, Melnic E, Coculescu M, Ceauşu RA, Raica M. Crosstalk between tumor blood vessels
heterogeneity and hormonal profile of pituitary adenomas: evidence and controversies. Anticancer Res. 2014
Oct;34(10):5413-20.
35. Poenaru Sava MG, Raica ML, Cimpean AM. VEGF mRNA Assessment in Human Pterygium: A New 'Scope' for a
Future Hope.Ophthalmic Res. 2014 Oct 3;52(3):130-135
36. Lozneanu L, Avădănei R, Cîmpean AM, Giuşcă SE, Amălinei C, Căruntu ID.RELATIONSHIP BETWEEN THE
PROANGIOGENIC ROLE OF EG-VEGF, CLINICOPATHOLOGICAL CHARACTERISTICS AND SURVIVAL IN
TUMORAL OVARY. Rev Med Chir Soc Med Nat Iasi. 2015 Apr-Jun;119(2):461-5.
10. Page 10/20 - Curriculum vitae of
Surname(s) First name()
Anca Maria Cimpean, MD, PhD
37. Cimpean AM, Raica M. Lymphangiogenesis and Inflammation-Looking for the "Missing Pieces" of the Puzzle. Arch
Immunol Ther Exp (Warsz). 2015 Jul 14. [Epub ahead of print]
38. Raluca BA, Cimpean AM, Cioca A, Cretu O, Mederle O, Ciolofan A, Gaje P, Raica M. Endothelial Cell Proliferation and
Vascular Endothelial Growth Factor Expression in Primary Colorectal Cancer and Corresponding Liver Metastases.
Asian Pac J Cancer Prev. 2015;16(11):4549-53.
39. Cimpean AM, Melnic E, Bălinişteanu B, Corlan A, Coculescu M, Rusu S, Raica M.Geographic-Related Differences of
Pituitary Adenomas Hormone Profile: Analysis of Two Groups Coming from Southeastern and Eastern Europe.Int J
Endocrinol. 2015;2015:192094. doi: 10.1155/2015/192094. Epub 2015 May 11.
40. Comşa Ş, Cîmpean AM, Raica M. The Story of MCF-7 Breast Cancer Cell Line: 40 years of Experience in Research.
Anticancer Res. 2015 Jun;35(6):3147-54. Review.
41. Fulga V, Rudico L, Balica AR, Cimpean AM, Saptefrati L, Raica M Invasive ductal carcinoma of no special type and its
corresponding lymph node metastasis: do they have the same immunophenotypic profile? Pol J Pathol. 2015
Mar;66(1):30-7.
42. Wenger FA, Szucsik E, Hoinoiu BF, Cimpean AM, Ionac M, Raica M. Circular anastomotic experimental fibrin sealant
protection in deep colorectal anastomosis in pigs in a randomized 9-day survival study. Int J Colorectal Dis. 2015
Aug;30(8):1029-39. doi: 10.1007/s00384-015-2260-4. Epub 2015 May 27.
43. Jitariu AA, Cimpean AM, Kundnani NR, Raica M. Platelet-derived growth factors induced lymphangiogenesis:
evidence, unanswered questions and upcoming challenges. Arch Med Sci. 2015 Mar 16;11(1):57-66. doi:
10.5114/aoms.2015.49217. Epub 2015 Mar 14.
44. Fulga V, Rudico L, Balica AR, Cimpean AM, Saptefrati L, Margan MM, Raica M Differential expression of e-cadherin in
primary breast cancer and corresponding lymph node metastases. Anticancer Res. 2015 Feb;35(2):759-65.
45. Oprea M, Popa I, Cimpean AM, Raica M, Poenaru DV. Microscopic assessment of degenerated intervertebral disc:
clinical implications and possible therapeutic challenge.In Vivo. 2015 Jan-Feb;29(1):95-102.
IV. Articles pulished in international journals
1. Gaje PN, Stoia-Djeska I, Cimpean AM, Ceausu RA, Tudorache V, Raica M. Lymphangiogenesis as a prerequisite in
the pathogenesis of lung fibrosis. In Vivo. 2014 May-Jun;28(3):367-73.
2. R. A. Popovici, R. A. Ceausu, A. M. Cimpean, T. Serban, M. Raica and P. N. Gaje. Mast cells as key players in
periodontal disease. ARCHIVES OF BIOLOGICAL SCIENCES, Vol. 66, No. 2, 2014
3. Cîrligeriu L, Cimpean AM, Raica M, Doroş CI. Dual role of podoplanin in oral cancer development. In Vivo. 2014
May-Jun;28(3):341-7.
4. Raica M, Cîmpean AM, Ceausu RA, Fulga V, Nica C, Rudico L, Saptefrati L. Hormone receptors and HER2
expression in primary breast carcinoma and corresponding lymph node metastasis: do we need both? Anticancer
Res. 2014 Mar;34(3):1435-40.
5. Cîrligeriu L, Cimpean AM, Raica M, Doroş CI. Dual role of podoplanin in oral cancer development. In Vivo. 2014
May-Jun;28(3):341-7
6. Gaje PN, Stoia-Djeska I, Cimpean AM, Ceausu RA, Tudorache V, Raica M. Lymphangiogenesis as a prerequisite in
the pathogenesis of lung fibrosis. In Vivo. 2014 May-Jun;28(3):367-73.
7. Cimpean AM, Crăiniceanu Z, Mihailovici D, Bratu T, Raica M. Human conchal cartilage and temporal fascia: an
evidence-based roadmap from rhinoplasty to an in vivo study and beyond. In Vivo. 2014 Jul-Aug;28(4):505-14.
8. Taban O, Cimpean AM, Raica M, Olariu S. PROX1 expression in gastric cancer: from hypothesis to evidence.
Anticancer Res. 2014 Jul;34(7):3439-46.
9. Globa T, Saptefrţi L, Ceauşu RA, Gaje P, Cimpean AM, Raica M. Mast cell phenotype in benign and malignant tumors
of the prostate. Pol J Pathol. 2014 Jun;65(2):147-53.
10. Bălinişteanu B, Cimpean AM, Melnic E, Coculescu M, Ceauşu RA, Raica M. Crosstalk between tumor blood vessels
heterogeneity and hormonal profile of pituitary adenomas: evidence and controversies. Anticancer Res. 2014
Oct;34(10):5413-20.
11. Poenaru Sava MG, Raica ML, Cimpean AM. VEGF mRNA Assessment in Human Pterygium: A New 'Scope' for a
Future Hope.Ophthalmic Res. 2014 Oct 3;52(3):130-135
12. Dehelean CA, Feflea S, Gheorgheosu D, Ganta S, Cimpean AM, Muntean D, Amiji MM. Anti-angiogenic and anti-
cancer evaluation of betulin nanoemulsion in chicken chorioallantoic membrane and skin carcinoma in Balb/c mice. J
Biomed Nanotechnol. 2013 Apr;9(4):577-89.
11. Page 11/20 - Curriculum vitae of
Surname(s) First name()
Anca Maria Cimpean, MD, PhD
13. Irina Stoia Djeska, Raluca Amalia Ceausu, Pusa Nela Gaje, Anca Maria Cimpean, O. Mederle, A. Nicodin, V.
Tudorache, and Marius Raica .The reticular network contributes to the staging of idiopathic lung fibrosis . ARCHIVES
OF BIOLOGICAL SCIENCES Vol. 65, No. 4, 2013
14. Adina Octavia Duse, Raluca Amalia Ceausu, Tibor Mezei, Anca Maria Cimpean, Pusa Gaje, Hortensia Ionita, Ioan
Jung, and Marius Raica. Expression and possible significance of vascular endothelial growth factor in non-Hodgkin
lymphoma. ARCHIVES OF BIOLOGICAL SCIENCES.Vol. 65, No. 2, 2013
15. Cimpean AM, Raica M. Intranodal hemorrhagic spindle cell tumor with amianthoid fibers - report of a case with
emphasis to mast cell reaction and d2-40 expression. In Vivo. 2013 May-Jun;27(3):395-9.
16. Doroş C, Balica N, Cîmpean AM. Dendritic cells: friends or foes of laryngeal cancer? Rom J Morphol Embryol.
2013;54(1):131-5.
17. Stoia-Djeska I, Ceauşu RA, Cîmpean AM, Nicodin A, Tudorache V, Raica M.From basic lesions to a pathological
staging of pulmonary fibrosis. Rom J Morphol Embryol. 2013;54(1):63-9.
18. Raica M, Cimpean AM, Ceausu R, Ribatti D, Gaje P. Interplay between mast cells and lymphatic vessels in different
molecular types of breast cancer. Anticancer Res. 2013 Mar;33(3):957-63.
19. Avram SF, Cimpean AM, Raica M. Behavior of the P1.HTR mastocytoma cell line implanted in the chorioallantoic
membrane of chick embryos. Braz J Med Biol Res. 2013 Jan 11;46(1):52-7
20. Ceausu RA, Cimpean AM, Dimova I, Hlushchuk R, Djonov V, Gaje PN, Raica M. Everolimus dual effects of an area
vasculosa angiogenesis and lymphangiogenesis. In Vivo. 2013 Jan-Feb;27(1):61-6.
21. Ribatti D, Nico B, Cimpean AM, Raica M, Crivellato E, Ruggieri S, Vacca A. B16-F10 melanoma cells contribute to
the new formation of blood vessels in the chick embryo chorioallantoic membrane through vasculogenic mimicry.
Clin Exp Med. 2013 May;13(2):143-7.
22. Pirtea L, Raica M, Cimpean AM. Endothelial cell activation and proliferation in ovarian tumors: two distinct steps as
potential markers for antingiogenic therapy response. Mol Med Rep. 2012 May;5(5):1181-4
23. Ş. Comşa, Anca Maria Cîmpean, Raluca Ceauşu, C. Suciu, and M. Raica Correlations between the vascular
endothelial growth factor expression, microvascular density in tumor tissues and TNM staging in breast cancer.
ARCHIVES OF BIOLOGICAL SCIENCES, Vol. 64, No. 2, 2012
24. Feflea S, Cimpean AM, Ceausu RA, Gaje P, Raica M. Effects of antibodies to EG-VEGF on angiogenesis in the chick
embryo chorioallantoic membrane. In Vivo. 2012 Sep-Oct;26(5):793-7.
25. Bălu S, Pirtea L, Gaje P, Cîmpean AM, Raica M. The immunohistochemical expression of endocrine gland-derived-
VEGF (EG-VEGF) as a prognostic marker in ovarian cancer. Rom J Morphol Embryol. 2012;53(3):479-83.
26. Cornea R, Cîmpean AM, Simu M, Cornea A, Suciu C, Raica M. Clinical, morphological and immunohistochemical
characterization of a recurrent B1 type thymoma. Rom J Morphol Embryol. 2012;53(3):639-43.
27. Gurzu S, Cimpean AM, Kovacs J, Jung I. Counting of angiogenesis in colorectal carcinomas using double
immunostain. Tumori. 2012 Jul-Aug;98(4):485-90.
28. Birau A, Ceausu RA, Cimpean AM, Gaje P, Raica M, Olariu T Assessement of angiogenesis reveals blood vessel
heterogeneity in lung carcinoma. Oncol Lett. 2012 Dec;4(6):1183-1186.
29. Duşe AO, Ceauşu RA, Mezei T, Cîmpean AM, Gaje P, Ioniţă H, Jung I, Raica M. The characterization of PDGFR-
alpha and PDGFR-beta expression in malignant non-Hodgkin lymphoma. Rom J Morphol Embryol. 2012;53(3
Suppl):749-53.
30. Duşe AO, Ceauşu RA, Cîmpean AM, Ioniţă H, Raica M, Gaje P. Heterogeneity of malignant non-Hodgkin lymphoma-
associated blood vessels. Rom J Morphol Embryol. 2012;53(4):985-8.
31. Duşe AO, Ceauşu RA, Mezei T, Cîmpean AM, Gaje P, Ioniţă H, Jung I. Mast cells contribute to the angiogenesis in
non-Hodgkin lymphoma. An immunohistochemical study based on the relationship with microvessel density. Rom J
Morphol Embryol. 2011;52(3 Suppl):1091-6.
32. Bălinişteanu B, Ceauşu RA, Cîmpean AM, Baciu I, Băculescu N, Coculescu M, Raica M. Conventional examination
versus immunohistochemistry in the prediction of hormone profile of pituitary adenomas. An analysis on 142 cases.
Rom J Morphol Embryol. 2011;52(3 Suppl):1041-5
33. Ceauşu RA, Cîmpean AM, Gaje P, Gurzu S, Jung I, Raica M. CD105/Ki67 double immunostaining expression in liver
metastasis from colon carcinoma. Rom J Morphol Embryol. 2011;52(2):613-6.
34. Raica M, Cimpean AM, Ceausu R, Ribatti D. Lymphatic microvessel density, VEGF-C, and VEGFR-3 expression in
different molecular types of breast cancer. Anticancer Res. 2011 May;31(5):1757-64.
35. Raica M, Mogoantă L, Kondylis A, Cîmpean AM. Angiogenesis in the human thymoma assessed by subclassification
of tumor-associated blood vessels and endothelial cells proliferation. Rom J Morphol Embryol. 2010;51(4):627-31
12. Page 12/20 - Curriculum vitae of
Surname(s) First name()
Anca Maria Cimpean, MD, PhD
36. Raica M, Coculescu M, Cimpean AM, Ribatti D. Endocrine gland derived-VEGF is down-regulated in human pituitary
adenoma. Anticancer Res. 2010 Oct;30(10):3981-6.
37. Raica M, Kondylis A, Mogoantă L, Encică S, Cîmpean AM. Diagnostic and clinical significance of D2-40 expression
in the normal human thymus and thymoma. Rom J Morphol Embryol. 2010;51(2):229-34.
38. Narita D, Anghel A, Cimpean AM, Izvernariu D, Cireap N, Ilina R, Ursoniu S. Interaction between estrogens and
androgen receptor genes microsatellites, prostate-specific antigen and androgen receptor expressions in breast
cancer. Neoplasma. 2010;57(3):198-206.
39. Ribatti D, Nico B, Cimpean AM, Raica M.Podoplanin and LYVE-1 expression in lymphatic vessels of human
neuroblastoma. J Neurooncol. 2010 Oct;100(1):151-2.
40. Sârb S, Cîmpean AM, Grigoraş D.Tie2 expression in human embryonic tissues. Rom J Morphol Embryol.
2010;51(1):81-4.
41. Cimpean AM, Ceauşu R, Raica M. Paraganglioma-like dermal melanocytic tumor: a case report with particular
features. Int J Clin Exp Pathol. 2009 Nov 20;3(2):222-5.
42. Cimpean AM, Seclaman E, Ceauşu R, Gaje P, Feflea S, Anghel A, Raica M, Ribatti D. VEGF-A/HGF induce Prox-1
expression in the chick embryo chorioallantoic membrane lymphatic vasculature. Clin Exp Med. 2010 Sep;10(3):169-
72.
43. Raica M, Cimpean AM, Nico B, Guidolin D, Ribatti D. A comparative study of the spatial distribution of mast cells and
microvessels in the foetal, adult human thymus and thymoma. Int J Exp Pathol. 2010 Feb;91(1):17-23.
44. Saptefraţi L, Cîmpean AM, Ciornîi A, Ceauşu R, Eşanu N, Raica M. Identification of lymphatic vessels and prognostic
value of lymphatic microvessel density in lesions of the uterine cervix. Rom J Morphol Embryol. 2009;50(4):589-94.
45. Raica M, Cîmpean AM, Meche A, Alexa A, Suciu C, Mureşan A.Analysis of the immunohistochemical expression of
mammaglobin A in primary breast carcinoma and lymph node metastasis. Rom J Morphol Embryol. 2009;50(3):341-
7.
46. Jung I, Gurzu S, Raica M, Cîmpean AM, Szentirmay Z. The differences between the endothelial area marked with
CD31 and CD105 in colorectal carcinomas by computer-assisted morphometrical analysis. Rom J Morphol Embryol.
2009;50(2):239-43.
47. Meche A, Cîmpean AM, Raica. Immunohistochemical expression and significance of epidermalgrowth factor receptor
(EGFR) in breast cancer. M. Rom J Morphol Embryol. 2009;50(2):217-21.
48. Raica M, Cimpean AM, Ribatti D. Angiogenesis in pre-malignant conditions. Eur J Cancer. 2009 Jul;45(11):1924-34.
49. Raica M, Jung I, Cîmpean AM, Suciu C, Mureşan AM. From conventional pathologic diagnosis to the molecular
classification of breast carcinoma: are we ready for the change? Rom J Morphol Embryol. 2009;50(1):5-13.
50. Suciu C, Cîmpean AM, Mureşan AM, Izvernariu D, Raica M. E-cadherin expression in invasive breast cancer. Rom
J Morphol Embryol. 2008; 49(4): 517-23.
51. Cîmpean AM, Suciu C, Ceauşu R, Tătucu D, Mureşan AM, Raica M. Relevance of the immunohistochemical
expression of cytokeratin 8/18 for the diagnosis and classification of breast cancer. Rom J Morphol Embryol.
2008;49(4):479-83.
52. Raica M, Cimpean AM, Ribatti D. The role of podoplanin in tumor progression and metastasis. Anticancer Res. 2008
Sep-Oct;28(5B):2997-3006.
53. Cîmpean AM, Raica M, Suciu C, Tătucu D, Sârb S, Mureşan AM. Vascular endothelial growth factor A (VEGF A) as
individual prognostic factor in invasive breast carcinoma. Rom J Morphol Embryol. 2008;49(3):303-8.
54. Raica M, Ribatti D, Mogoanta L, Cimpean AM, Ioanovici S. Podoplanin expression in advanced-stage gastric
carcinoma and prognostic value of lymphatic microvessel density. Neoplasma. 2008;55(5):455-60.
55. Raica M, Cimpean AM, Ribatti D. Myasthenia gravis and the thymus gland. A historical review. Clin Exp Med. 2008
Jun;8(2):61-4.
56. Gurzu S, Jung J, Azamfirei L, Mezei T, Cîmpean AM, Szentirmay Z. The angiogenesis in colorectal carcinomas with
and without lymph node metastases. Rom J Morphol Embryol. 2008;49(2):149-52.
57. Suciu C, Cîmpean AM, Raica M. Neural granular cell tumor. A case report. Rom J Morphol Embryol. 2008;49(1):111-
4.
58. Raica M, Mogoantă L, Cîmpean AM, Alexa A, Ioanovici S, Mărgăritescu C, Lazăr D, Izvernariu D.
Immunohistochemical expression of vascular endothelial growth factor (VEGF) in intestinal type gastric carcinoma.
Rom J Morphol Embryol. 2008;49(1):37-42.
59. Ieremia G, Raica M, Cîmpean AM, Bocan V. Morphologic and histochemical changes in the skin of patients with
scleroderma. Rom J Morphol Embryol. 2007;48(4):361-7.
13. Page 13/20 - Curriculum vitae of
Surname(s) First name()
Anca Maria Cimpean, MD, PhD
60. Gurzu S, Jung J, Azamfirei L, Mezei T, Cîmpean AM. The aspects of angiogenesis in anal canal carcinomas
compared with that in colorectal carcinomas. Rom J Morphol Embryol. 2007;48(4):349-53.
61. Mocanu L, Cîmpean AM, Raica M. Expression of cytokeratin MNF116 and vimentin in pleural serous effusions. Rom
J Morphol Embryol.2007; 48(3):291-4.
62. Gaje P, Bocan V, Cîmpean AM, Izvernariu DA, Streian F, Raica M. Simultaneous demonstration of mast cells and
blood vessels by the combined method CD34--alcian blue-safranin in lip tumors. Rom J Morphol Embryol.
2007;48(3):237-41.
63. Raica M, Cimpean AM, Anghel A Immunohistochemical expression of vascular endothelial growth factor (VEGF)
does not correlate with microvessel density in renal cell carcinoma. Neoplasma. 2007;54(4):278-84.
64. Cîmpean AM, Raica M, Izvernariu DA, Tătucu D. Lymphatic vessels identified with podoplanin. Comparison of
immunostaining with three different detection systems. Rom J Morphol Embryol. 2007;48(2):139-43.
65. Raica M, Cîmpean AM, Encică S, Cornea R. Involution of the thymus: a possible diagnostic pitfall. Rom J Morphol
Embryol. 2007;48(2):101-6.
66. Cîmpean AM, Raica M, Suciu C. CD105/smooth muscle actin double immunostaining discriminate between immature
and mature tumor blood vessels. Rom J Morphol Embryol. 2007;48(1):41-5.
67. Raica M, Cîmpean AM, Encică S, Scridon T, Bârsan M. Increased mast cell density and microvessel density in the
thymus of patients with myasthenia gravis. Rom J Morphol Embryol. 2007;48(1):11-6.
68. Mocanu L, Cîmpean AM, Raica M. Value of antimesothelioma HBME-1 in the diagnosis of inflammatory and
malignant pleural effusions. Rom J Morphol Embryol. 2006;47(4):351-5.
69. Raica M, Encică S, Motoc A, Cîmpean AM, Scridon T, Bârsan M. Structural heterogeneity and immunohistochemical
profile of Hassall corpuscles in normal human thymus. Ann Anat. 2006 Jul;188(4):345-52.
70. Baneth V, Raica M, Cîmpean AM. Assessment of angiogenesis in soft-tissue tumors. Rom J Morphol Embryol.
2005;46(4):323-7.
71. Narita D, Cimpean AM, Anghel A, Raica M. Prostate-specific antigen value as a marker in breast cancer. Neoplasma.
2006;53(2):161-7.
72. Cîmpean AM, Raica M, Nariţa D. Diagnostic significance of the immunoexpression of CD34 and smooth muscle cell
actin in benign and malignant tumors of the breast. Rom J Morphol Embryol. 2005;46(2):123-9.
73. Raica M, Zylis D, Cîmpean AM Cytokeratin 20, 34betaE12 and overexpression of HER-2/neu in urine cytology as
predictors of recurrences in superficial urothelial carcinoma. Rom J Morphol Embryol. 2005;46(1):11-5.
74. Raica M, Cimpean AM, Encica S, Motoc A. Lymphocyte-rich Hassall bodies in the normal human thymus. Ann Anat.
2005 Apr;187(2):175-7.
75. Cîmpean AM, Raica M, Encica S. Overexpression of cytokeratin 34beta E12 in thymoma: could it be a poor prognosis
factor? Rom J Morphol Embryol. 1999-2004;45:153-7.
76. Raica M, Encica S, Mogoanta L, Suciu C, Cîmpean AM, Margaritescu C.Thymus and thymoma: what's new? Rom J
Morphol Embryol. 1999 2004;45:11-24.
V. Other works and scientific contributions.
V.1. Articles published in romanian journals recognized by CNCSIS as B+
1. Birau A, Ceausu RA, Cimpean AM, Gaje P, Feflea S, Ciobanu G, Olariu T, Raica M. The prognostic value of
microvascular density in lung carcinomas. Studia Universitatis “Vasile Goldiş”, Seria Ştiinţele Vieţii. 22 (1): 17-23,
2012
2. Birau A, Ceausu RA, Cimpean AM, Gaje P, Ciobanu G, Olariu T, Raica M. Patterns of the vascular endothelial
growth factor immune-histochemical
expression in lung carcinomas. Studia Universitatis “Vasile Goldiş”, Seria Ştiinţele Vieţii. 22 (1): 11-17, 2012
3. Raica, M, Muresan, AM , Cimpean, AM, Suciu, C . Clinical significance of androgen receptor expression in breast
cancer. Acta Endocrinologica-Bucharest , 2009, 5 ; 4 : 459-469.
V.2. Abstract published in abstract books of international conferences
14. Page 14/20 - Curriculum vitae of
Surname(s) First name()
Anca Maria Cimpean, MD, PhD
1. Maria Corina Stanciulescu, Calin Marius Popoiu, |Laurentiu Vlad David, Marius Raica, Anca Maria Cimpean,
Eugen Sorin Boia. Β1-adrenergic receptor expression in the vascular abnormalities in human and experimental
model. EUPSA 2014, Dublin, Ireland, pp. 132.
2. Cimpean AM, Encica S, Raica M. Expression and potential role of SOX2 gene in human thymus and thymomas.
21st Meeting of the European Association for Cancer Research, 26-29 June 2010, Oslo, Norway, European Journal
of Cancer, suppl 8, no.5, pp:174, pg:1, 2010
3. Gaje P, Cimpean AM, Raica M, Ribatti D. Lymphatic microvessel density and mast cells in molecular types of
breast cancer. 21st Meeting of the European Association for Cancer Research, 26-29 June, 2010, Oslo, Norway,
European Journal of Cancer, suppl 8, no.5, pp. 188, pg 1, 2010.
4. Ceausu AR, Gurzu S, Gaje P, Jung I, Raica M, Cimpean AM. Prox 1 expression in liver metastases from colon
carcinoma. 21st Meeting of the European Association for Cancer Research, 26-29 June 2010, Oslo, Norway,
European Journal of Cancer, suppl 8, no.5, pp. 127, pg:1, 2010
5. Raica M, Gaje P, Ceausu AR, Cimpean AM. Clinical significance of lymphangiogenesis in molecular types of
invasive breast cancer. 21st Meeting of the European Association for Cancer Research, 26-29 June, Oslo, Norway,
European Journal of Cancer, suppl 8, no.5, pp.126, pg:1, 2010.
6. Iurciuc Mircea, M; Avram, A; Iurciuc, S; Gaita, D; Cimpean, A; Duda-Seiman, D; Ciorica, G; Mancas, S. Physical
Training May Improve Some of the Ambulatory Blood Pressure Monitoring Parameters: Pp.8.325, Journal of
Hypertension:,June 2010 - Volume 28 - Issue - p e147
7. Jung I, Gurzu S, Szentirmay Z, Mezei T, Cimpean AM, Raica M. The microsatellite instability and its correlation s
incolorectal carcinomas. 22nd European Congress of Pathology, Florence, Italy, 2009, publicat în Virchow Archiv,
, Suppl. 1, 455, pp:17-18,pg:1, 2009
8. Gurzu S, Mezei T, Raica M, Cimpean A, Szentirmay J, Jung I. Prognostic markers and angiogenesis in diffuse
large B cell lymphoma and follicular lymphoma. 22nd European Congress of Pathology, Florence, Italy, 2009,
publicat în Virchow Archiv, , Suppl. 1, 455, pp:17-18,pg:1, 2009
9. Cimpean AM, Seclaman E, Ferician O, Feflea S, Ceausu R, Gaje P, Anghel A. Effects of combined VEGF/HGF
on chick embryo chorioallantoic membrane, ESH interdisciplinary Conference Angiogenesis 6-7 june, 2009,
Helsinki, Finland, poster 11, 2009.
10. Mederle N, Mederle O, Ceausu R, Cimpean AM, Raica M, Darabus Gh. Observation and immunohistochemical
detection of spontaneous Cryptosporidium parvum infection in lambs. III International Giardia and Cryptosporidium
Conference, 11-15 octombrie, Orvieto, Italy, p103, pg1, 2009.
11. Raica M, Cimpean AM. Angiogenesis in developing and postnatal human thymus. Third European Conference on
Tumor Angiogenesis and Antiangiogenic Therapy, Abano Terme, Padova, Italy, November 6-8, Abstract Book,
pp.105,pg:1, 2008
12. Cimpean AM, Raica M, Sarb S. Tie2, CD34 and CD133 expression in the vascular network from mesenchyme
and differentiated tissues of the human embryo. Third European Conference on Tumor Angiogenesis and
Antiangiogenic Therapy, Abano Terme, Padova, Italy, November 6-8, Abstract Book, pp. 74,pg:1, 2008.
13. Cimpean AM, Raica M, Oasim D, Ceausu R, Gaje P, Bocan V., Ferician O, Poenaru DV, Iacovliev M. Changes in
immunophenotype, behaviour and microcirculation of human tumors implanted on the chick chorioallantoic
membrane. 25th Conference of the European Society of Microcirculation, Budapest, Hungary, 26-29 August 2008,
Abstract publicat in Journal of Vascular Research, suppl 2, 45, pp: 61, pg1, 2008
14. Raica M, Jung I, Cimpean AM, Gurzu S., Suciu C. Lymphangiogenesis detected by D2-40, VEGF-C, and VEGFR3
expression in molecular subtypes of breast carcinoma. 25th Conference of the European Society of
15. Page 15/20 - Curriculum vitae of
Surname(s) First name()
Anca Maria Cimpean, MD, PhD
Microcirculation, Budapest, Hungary, 26-29 August 2008, Abstract publicat in Journal of Vascular Research, suppl
2, 45, pp: 63, pg:1, 2008.
15. Raica M, Gaje P., Mederle N., Cimpean AM. Podoplanin expression in tumor cells of canine mastocytoma. A case
report. 3rd Intercontinental Congress of Pathology, 16-22 mai 2008, Barcelona, Spania, rezumat publicat in
Virchow Archive, Suppl 1, P491, S253
16. Cimpean AM, Raica M, Gurzu S, Jung I. Podoplanin expression and lymphatic microvessel density in colorectal
carcinomas. Correlations with histopathologic types. 3rd Intercontinental Congress of Pathology, 16-22 mai,
Barcelona, Spania, rezumat publicat in Virchow Archive, Suppl 1, p383, S139, pg;1, 2008
17. Suciu C, Cimpean AM , Izvernariu D, Raica M. E Cadherin expression in invasive breast cancer correlate with
grade of the tumor. 3rd Intercontinental Congress of Pathology, 16-22 mai, Barcelona, Spania, rezumat publicat in
Virchow Archive, Suppl 1, pp:228, S139, pg:1, 2008
18. Gurzu S, Cimpean AM, Raica M, Jung I, Mezei T, Azamfirei L. Angiogenesis and vessels maturation grade in
colorectal carcinomas. 3rd Intercontinental Congress of Pathology, 16-22 mai, Barcelona, Spania, rezumat publicat
in Virchow Archive, Suppl 1, pp:381, S139, pg:1, 2008
19. Gurzu S, Jung I, Szentirmay J, Pavai Z, Cimpean AM, Raica M. The aspect of endothelial area in colorectal
carcinomas. 27th Congress of International Academy of Pathology, 12-17 octombrie, Atena, rezumat publicat în
Histopathology, 53, Sp Issue 1, pp:136-137, pg.2, 2008.
20. Ceauşu R, Jung I, Gurzu S, Cimpean AM, Raica M. Expression of VEGF and VEGF receptors in liver metastasis
from colon. XXInternational symposyum on Morphological Sciences, Timişoara,12-16 Septembrie , P54, pg:1,2008
21. Gaje P, Cimpean AM, Bocan V, Ceausu R, Suciu C, Raica M. The determination and the distribution of mast cells
in the mammary gland comparatively in alcian blue safranin and anti triptase antibody staining. XXInternational
symposyum on Morphological Sciences,Timişoara, Romania, 12-16 Septembrie, P82, pg:1, 2008
22. Cimpean AM, Raica M. Microvessel density, pro and contra. XXInternational symposyum on Morphological
Sciences, Timisoara, Romania, 12-16Septembrie, P65, pg 1, 2008
23. Mezei T, Gurzu S, Cimpean AM, Raica M. Angiogenesis in malignant lymphomas and ways to measure it.
XXInternational symposyum on Morphological Sciences, Timisoara, Romania, 12-16Septembrie,pp 165, pg:1,
2008.
24. Sarb S, Raica M, Cimpean AM. Tie 2 and CD133 expression in the human embryo mesenchyme. XXInternational
symposyum on Morphological Sciences, Timisoara, Romania, 12-16Septembrie, pp 232, pg:1, 2008.
25. Miclea F, Cîmpean AM, Bocan V, Raica M.- Apoptosis and DNA repair in hormone sensitive and insensitive
prostate carcinoma, Annual EAU Congress, Berlin,21-24 March, rezumat publicat în European Urology
Supplements , 6(2), pp: 47, pg1,2007
26. Koreck A, Szecheny A, Cimpean A, Bella Z, Garaczi E, Raica M, Rasko I, Kemeny L. DNA damage and repair in
nasal mucosa after rinophototherapy. 26th Congress of the European-Academy-of-Allergology-and-Clinical-
Immunology, Allergy, Suppl 83, 62, pp230-231, pg:2, 2007.
27. Raica M, Cîmpean AM. Immunohistochemical expression of vascular endothelial growth factor does not correlate
with microvessel density in renal cell carcinoma. 2nd European Conference on Tumor Angiogenesis and
Antiangiogenic Therapy, septembrie Munchen, Germania, rezumat publicat în Angiogenesis, Springer, Suppl.1,
vol.9, pp.24-25, pg:2, 2006
28. Cimpean AM, Raica M, Encica M, Cornea M, Bocan V. Immunohistochemical expression of vascular endothelial
growth factor in normal and pathologic conditions of the human thymus. 2nd European Conference on Tumor
16. Page 16/20 - Curriculum vitae of
Surname(s) First name()
Anca Maria Cimpean, MD, PhD
Angiogenesis and Antiangiogenic Therapy, septembrie Munchen, Germania, rezumat publicat în Angiogenesis,
Springer, Suppl.1, vol.9,pp.24, pg:1, 2006
29. Cimpean AM, Raica M., Suciu C. CD105/Smooth muscle actin double immunostaining discriminate between
immature and mature tumor blood vessels. 17 th Ljudevit Jurak International Symposium on Comparative
Pathology, Zagreb, Croaţia, rezumat publicat în Acta Clin Croatia. Vol 45, Suppl.1, pp. 48,pg.1, 2006
30. Raica M, Cimpean AM, Martin V., Mederle O. The proliferative activity of endothelial cells assessed by the
immunohistochemical expression of Ki 67 and PCNA in soft tissue tumors-associated angiogenesis. 17 th Ljudevit
Jurak International Symposium on Comparative Pathology, Zagreb, Croaţia, rezumat publicat în Acta Clin Croatia.
Vol 45, Suppl.1, p. 47, 2006.
31. Mederle O., Ioanovici S., Raica M., Cimpean AM, Izvernariu D. Microvessel density and mast cell density
correlate with the immunohistochemical expression of vascular endothelial growth factor in gastric carcinoma. 17
th Ljudevit Jurak International Symposium on Comparative Pathology, Zagreb, Croaţia, rezumat publicat în Acta
Clin Croatia. Vol 45, Suppl.1, pp. 38, pg:1, 2006.
V.3. Abstracts published in national conferences abstract books.
1. Ceauşu R, Cîmpean AM, Gaje P, Mederle O, Gurzu S, Jung I, Raica M. Expresia dublei imunocolorări CD105/Ki67
în metastazele hepatice ale cancerului de colon. Al VIII Simpozion Naţional al Societăţii Romăne de Morfologie,
Craiova, 26-30 mai, volum rezumate, P48,pg:1, 2009
2. Gaje P, Cîmpean AM, Ceauşu R. Reacţia mastocitară în tumori maligne din regiunea capului şi gîtului. Al VIII
Simpozion Naţional al Societăţii Romăne de Morfologie, Craiova, 26-30 mai, volum rezumate, p79,pg.1, 2009
3. Cimpean AM, Raica M, Ceauşu R, Gaje P, Encică S. Expresia PDGF, PDGFR alfa şi FGFR3 în timusul uman
normal şi tumorile timice. Al VIII Simpozion Naţional al Societăţii Romăne de Morfologie, Craiova, 26-30 mai, p70,
pg 1,2009
4. Izvernariu DA, Cîmpean AM, Suciu C, Raica M. Morphometric patterning of lymphatic vessels in breast cancer.
Correlation with VEGF-C expression and lymph node involvement. Al VIII Simpozion Naţional al Societăţii Romăne
de Morfologie, Craiova, 26-30 mai, volum rezumate, p80, pg 1, 2009
5. Iancu C, Glăja R, Izvernariu DA, Cîmpean AM, Lazăr E, Nicodin A. Sclerosing hemangioma of the lung. A case
presentation. Al VIII Simpozion Naţional al Societăţii Romăne de Morfologie, Craiova, 26-30 mai, volum rezumate,
p197, pg 1, 2009
6. Muresan A, Lazar E, Dema A, Corneanu M, Raica M, Suciu C, Cimpean AM., Cirorboreanu R, Sargan I. Utilitatea
determinării proteinei P53 IN carcinomanele invazive de glanda mamară.IX lea Congres Notional al Societăţii
Române de Morfologie, Craiova, 28-31 mai, volum rezumate, p:268, pg:1, 2008
7. Narita D, Raica M, Motoc M, Cimpean AM. Immunophenotypical analysis of ER negative breast carcinomas. IX
lea Congres National al Societăţii Romăne de Morfologie, Craiova, 28-31 mai, volum rezumate, p269, pg 1, 2008
8. Cimpean AM, Suciu C, Ceausu R, Tatucu D, The immunohistochemical expression of VEGF and VEGFR2 in
molecular types of breast cancer. IX lea Congres National al Societăţii Romăne de Morfologie, Craiova, 28-31 mai,
volum de rezumate, p.92, pg:1, 2008
9. Cimpean AM, Raica M, Anghel A, Ceausu R, Gaje P, Ferician O, Sarb S, Seclaman E, Tatucu D. Macroscopic
and microscopic effects of pBAlst VEGF on chick chorioallantoic membrane. IX lea Congres National al Societăţii
Române de Morfologie, Craiova, 28-31 mai, volum rezumate p93, pg:1, 2008
17. Page 17/20 - Curriculum vitae of
Surname(s) First name()
Anca Maria Cimpean, MD, PhD
10. Sarb S, Raica M, Ferician O, Cimpean AM, Ceausu R, Tatucu D. Progenitor endothelial cells identification in the
human embryo mesenchyme. IX lea Congres National al Societăţii Romăne de Morfologie, Craiova, 28-31 mai,
volum rezumate p93, 2008
11. Raica M, Suciu C, Cimpean AM.From the conventional pathologic diagnosis to the molecular classification of
breast carcinomas: are we ready for change. IX lea Congres National al Societăţii Romăne de Morfologie, Craiova,
28-31 mai, volum rezumate, p.135, pg 1, 2008
12. Izvernariu D, Carligeriu L, Gaje P, Cimpean AM, Bocan V. Correlation of mast cells density with lymphatic vessels
density in lip carcinomas. IX lea Congres National al Societăţii Romăne de Morfologie, Craiova, 28-31 mai,volum
rezumate p.106, pg.1, 2008
13. Izvernariu D, Muresan A, Cimpean AM, Suciu C. Possible involvement of the mast cells in intranodal
lymphangiogenesis during breast cancer spreading. IX lea Congres National al Societăţii Române de Morfologie,
Craiova, 28-31 mai, volum rezumate p.107, pg.1, 2008
14. Gurzu S, Jung I, Mezei T, Cimpean AM, Raica M, Szentirmay Z. The correlation between angiogenesis, lymph
node status and localosation of the colon segments in colorectal carcinomas. IX lea Congres National al Societăţii
Române de Morfologie, Craiova, 28-31 mai, p.102, pg.1, 2008
15. Gaje P, Cimpean AM, Bocan V, Ceausu R, Izvernariu D, Suciu C. Determinarea distribuşiei şi densităţii
mastocitelir in tumorile glandei mamareîn coloratiiile AAS si anti triptază mastocitară. IX lea Congres National al
Societăţii Române de Morfologie, Craiova, 28-31 mai, p.100,pg.1, 2008
16. Gaje P, Cimpean AM, Ceausu R, Bocan V, Izvernariu D. Identificarea simultană a mastocitelor şi vaselor sanguine
in tumorile maligne gastrice. Al IX lea Congres Notional al Societăţii Romăne de Morfologie, Craiova, 28-31 mai,
volum rezumate p.99,pg.1, 2008
17. Bocan V, Gaje P, Ceausu R, Cimpean AM, Izvernariu D; Tatucu D. Corelatia intre microdensitatea vasculară şi
indexul de proliferare în tumorile maligne gastrice. IX lea Congres National al Societăţii Romăne de Morfologie,
Craiova, 28-31 mai, p.84 ,pg.1, 2008
18. Bocan V, Cîmpean AM, Koreck A, Gaje P, Streian F, Raica M. Expresia dimerilor de timină în tumorile maligne
ale buzei. Al XXXVII-lea Simpozion de Morfologie Normală şi Patologică, Al VI-lea Simpozion de Morfologie
Microscopică, Craiova, volum rezumate p.31, pg.1, 2006.
19. Cimpean AM, Raica M, Izvernariu DA, Tătucu D., Immunohistochemical expression of podoplanin; comparison of
immunostaining with three different detection systems. Conferinţa Memodic, 12-15 aprilie, rezumat publicat în
Revista de Medicină şi Farmacie a UMF Tg Mureş, 53, p: 31,pg.1, 2007
20. Raica M, Cîmpean AM. Imunohistochimia în angiogeneza tumorală:ce ne spune şi ce nu ne spune. Conferinţa
Memodic, 12-15 aprilie, rezumat publicat în Revista de Medicină şi Farmacie a UMF Tg Mureş, 53, p: 22,pg.1,
2007
21. Raica M, Cîmpean AM. Clinical significance of vascular endothelial growth factor (VEGF) immunohistochemical
expression in solid tumors. Fiziologia, 17, p:6,pg.1 volum de rezumate al conferinţei naţionale Endothelial cell and
tumor angiogenesis, Timişoara,19-21 aprilie, 2007
22. Cîmpean AM, Raica M. Heterogeneity of tumor blood vessels: clinical and therapeutic aspects. Fiziologia, 17:p9,
pg.1 volum de rezumate al conferinţei naţionale Endothelial cell and tumor angiogenesis, Timişoara,19-21 aprilie,
2007.
23. Cîmpean AM, Raica M, Anghel A, Seclaman E, Olimpiu F, Gaje P, Ferician O, Tătucu D.- The effect of pBLAST49-
hVEGF on vasculature of chick chorioallantoic membrane. Fiziologia, 17:p10, pg.1,volum de rezumate al
conferinţei naţionale Endothelial cell and tumor angiogenesis, Timişoara,19-21 aprilie 2007
18. Page 18/20 - Curriculum vitae of
Surname(s) First name()
Anca Maria Cimpean, MD, PhD
24. Raica M, Alexa A, Cîmpean AM, Baneth V. – Endothelial cell proliferation rate during angiogenesis in soft tissue
tumors. Fiziologia, 17:p10-11, pg.1, volum de rezumate al conferinţei naţionale Endothelial cell and tumor
angiogenesis, Timişoara,19-21 aprilie 2007
25. Izvernariu DA, Cîmpean AM, Raica M.- Simultanous assessment of lymphatic vessel density and mast cell density
by combined immunohistochemical and histochemical methods in lip tumours. Fiziologia, 17:p14, pg.1, volum de
rezumate al conferinţei naţionale Endothelial cell and tumor angiogenesis, Timişoara,19-21 aprilie 2007
26. Cîmpean AM, Raica M, Koreck A.- Expresia dimerilor de timină şi a markerilor pentru apoptoză în piele şi
mucoasa nazală., volum rezumate Al- VII-lea Simpozion de morfologie microscopică, Craiova, 16-20 mai., p27,
pg.1, 2007
27. Alexa A, Raica M, Cîmpean AM.- Variante particulare ale involuţiei timusului., volum rezumate Al- VII-lea
Simpozion de morfologie microscopică, Craiova, 16-20 mai., p27, pg.1,2007.
28. Cîmpean AM, Encică S, Raica M.-Displazia timică neclasificabilă. Prezentare de caz., volum rezumate Al- VII-lea
Simpozion de morfologie microscopică, Craiova, 16-20 mai., p70., pg.1, 2007
29. Raica M., Cîmpean AM. Implicaţiile prognostice şi terapeutice ale angiogenezei în tumorile colorectale. Al XXXVII-
lea Simpozion de Morfologie Normală şi Patologică, Al VI-lea Simpozion de Morfologie Microscopică, Craiova,
rezumat p.31,pg.1, 2006.
30. Cîmpean AM, Raica M., Encică S, Bocan V, Cornea R.,.Izvernariu D.A. VEGF în timusul normal şi patologic. Al
XXXVII-lea Simpozion de Morfologie Normală şi Patologică, Al VI-lea Simpozion de Morfologie Microscopică,
Craiova, rezumat p.38, pg.1, 2006.
31. Gaje P, Cîmpean AM, Bocan V, Izvernariu D.A.,Streian F,.Raica M. Demonstrarea simultană a mastocitelor şi
vaselor sanguine prin metoda combinată CD34-AAS în tumorile buzei. Al XXXVII-lea Simpozion de Morfologie
Normală şi Patologică, Al VI-lea Simpozion de Morfologie Microscopică, Craiova, rezumat p.40, pg.1, 2006.
32. Izvernariu D.A., Raica M., Cîmpean AM, Gaje P, Bocan V. Angiogeneza în cancerul gastric: microdensitatea
vasculară în corelaţie cu reacţia mastocitară şi expresia VEGF-A. Al XXXVII-lea Simpozion de Morfologie Normală
şi Patologică, Al VI-lea Simpozion de Morfologie Microscopică, Craiova, rezumat p.43, pg.1, 2006.
33. Cornea R., Dema A, Cornianu M, Cîmpean AM, Bocan V, Raica M.. Timus ectopic adiacent tiroidei şi paratiroidei.
Prezentare a două cazuri Al XXXVII-lea Simpozion de Morfologie Normală şi Patologică, Al VI-lea Simpozion de
Morfologie Microscopică, Craiova, rezumat p.71, pg.1, 2006.
34. Raica M., Encică S, Cîmpean AM. Variantă neobişnuită de corpuscul Hassall în timusul uman normal. Al XXXV-
lea Simpozion de Morfologie Normală şi Patologică, Al IV-lea Simpozion de Morfologie Microscopică, Craiova,
rezumat p.186, pg.1, 2006.
35. Cîmpean AM, Raica M, Suciu C, Izvernariu D – Contribuţii la diferenţierea vaselor imature şi mature în
angiogeneza tumorală. Simpozionul de Morfologie Microscopică, Craiova, 12-15 Mai, p.31, pg.1, 2005.
36. Mederle O, Izvernariu D, Raica M, Cîmpean AM – Evaluarea studiului angiogenezei placentare la termen.
Simpozionul de Morfologie Microscopică, Craiova, 12-15 Mai, p.80, pg.1, 2005.
37. Raica M, Cîmpean AM, Nariţa D – Semnificaţia diagnostică a expresiei CD34 şi actinei de tip muşchi neted în
tumorile mamare benigne şi maligne. Simpozionul de Morfologie Microscopică, Craiova, 12-15 Mai, rezumat p.120,
pg.1, 2005.
38. Mocanu L, Cîmpean AM, Raica M. Valoarea HBME-1 în diagnosticul pleureziilor inflamatorii şi maligne.
Simpozionul de Morfologie Microscopică, Craiova, 12-15 Mai, p.85, pg.1, 2005.
19. Page 19/20 - Curriculum vitae of
Surname(s) First name()
Anca Maria Cimpean, MD, PhD
39. Raica M, Cîmpean AM. Celula endotelială ţintă pentru terapia antiangiogenică. Al XXXV-lea Simpozion de
Morfologie Normală şi Patologică, Al IV-lea Simpozion de Morfologie Microscopică, Craiova, rezumat p.60-62,
pg.2, 2004.
40. Cîmpean AM, Raica M, Encică S, Microdensitatea vasculară în timusul normal, tumorile timice şi miastenia gravis.
Al XXXV-lea Simpozion de Morfologie Normală şi Patologică, Al IV-lea Simpozion de Morfologie Microscopică,
Craiova, rezumat p.107, pg.1, 2004,.
41. Cîmpean A, Raica M, Herman I. Microdensitatea vasculară în cancerul prostatei în stadiul avansat. Al III-lea
Simpozion de Morfologie Microscopică cu participare internaţională, Craiova, rezumat p.193, pg.1, 2003.
V.4. Oral presentations at international conferences.
1.
2. Cimpean AM, Raica M, Sava-Poenaru M. The molecular profile of human pterygium-do will need it or not?
International Journal Of Molecular Medicine Volume: 30 Supplement: 1 Pages: S14-S14 Meeting
Abstract: 137 , 2012, Creta, Greece.
3. Raica M, Cîmpean AM, Gaje P. Semnificaţia clinică a clasificării moleculare a cancerului mamar. Congresul III
Naţional de Oncologie, Chişinău, volum de rezumate, p61, pg.1, 2010.
4. Cimpean AM, Raica M. The chick embryo chorioallantoic membrane as an in vivo model to study tumor
angiogenesis and metastasis. 8th International Conference of Anticancer Research, Kos, Greece, October 17-22,
vol.28, 5C, 2008
5. Raica M, Cîmpean AM. Lymphangiogenesis as a potential target for tumor therapy. 8th International Conference
of Anticancer Research, Kos, Greece, October 17-22, vol.28, 5C, 2008
6. Cîmpean AM, Raica M, Suciu C, Ceauşu R. VEGF and its receptor VEGFR2 as potential markers for molecular
classification of breast cancer.Actualităţi în diagnosticul şi tratamentul contemporan al tumorilor organelor
reproductive la femei. Simpozion dedicat prof. Bohman., Chişinău ,p188, pg.1, , 2008.
7. Raica M, Suciu C, Cîmpean AM. Impactul prognostic şi terapeutic al clasificării moleculare a cancerului mamar.
Actualităţi în diagnosticul şi tratamentul contemporan al tumorilor organelor reproductive la femei. Simpozion
dedicat prof. Bohman., Chişinău ,p187, pg.1, 2008.
V.5. Lectures for students and participant as lector at postgraduate courses .
1. Cîmpean AM. Curs de Imunomorfologie pentru studenţii anului II Medicină Generală. Litografia UMF Timişoara,
octombrie 2009
2. Raica M, Căruntu ID, Cîmpean AM, Suciu C. Histologia organelor, curs pentru studenţii anului II Medicină
Generală, Lito UMF “Victor Babeş” Timişoara, 2009
3. Raica M, Encică S, Cîmpean AM, Scridon T, Simu G, Bârsan M, Suciu C. Patologia timusului. Manual curs
postuniversitar, Lito UMF Timişoara februarie, 2007,
4. Raica M, Cîmpean AM, Lazăr E, Căruntu ID, Suciu C, Alexa A, Mederle O, Gaje p, Mărgăritescu C. Izvernariu D.
Celula endotelială şi angiogeneza tumorală. Manualul Cursului. Lito UMF Timişoara, aprilie 2007
5. Raica M, Cîmpean AM, Suciu C. Imunohistochimie: tehnică, interpretare şi implicaţii în diagnosticul microscopic
al tumorilor maligne. Chişinău, Republica Moldova, 2006
20. Page 20/20 - Curriculum vitae of
Surname(s) First name()
Anca Maria Cimpean, MD, PhD
6. Raica M, Mederle O, Suciu C, Cîmpean AM, Gaje P. Histologia pentru patolog. Curs postuniversitar, Cluj Napoca,
2006.
7. Lazăr E, Jung I, Raica M, Nica C, Simu G, Lazăr E, Coculescu M, Anghel A, Roşianu AM, Dema A, Mărgăritescu
C, Nica C, Suciu C, Gyenes C, Glăja R, Cîmpean AM, Sava A, Poiana C. Patologia tumorilor mamare:implicaţii
diagnostice, prognostice şi terapeutice, Lito UMF Timişoara, aprilie 2005.
8. Raica M. Dema E, Alexa A, Iacovliev M, Sîrb S, Mederle O, Cîmpean AM. Citologie clinică volumul II. Editura
Mirton, 1996.